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Chia-Chun Tang 
THE EXPERIENCE AND COMMUNICATION OF SYMPTOMS IN ADVANCED 
PANCREATIC CANCER PATIENTS AND THEIR FAMILIES 
Symptom management is the main focus of care for patients living with advanced 
pancreatic cancer (APC). However, evidence shows that symptom management is far 
from satisfactory for this population. Poorly managed symptoms have had a profound 
negative impact on APC patients’ and caregivers’ life. While communicating symptoms 
with healthcare providers is the first step to achieve effective symptom management, 
some studies have revealed the poor quality of symptom discussions among cancer 
patients, their caregivers, and healthcare providers.  
The purpose of this dissertation was to advance the sciences of nursing, symptom 
management, and patient/caregiver and provider communication in patients with APC. 
Chapter two, three, and four represented three sub-studies which addressed three specific 
aims: (1) synthesizing the current evidence regarding the symptom experience of patients 
with APC, (2) examining recorded healthcare encounters between patients with APC, 
their caregivers, and healthcare providers to better understand the symptom experiences 
of patients with APC as told to their healthcare providers, and (3) developing a typology 
describing patterns and essential elements of real discussions between APC patients/ 
caregivers and healthcare providers in regards to symptoms. Specifically, chapter two 
was an integrative review which synthesized sixteen quantitative studies (n=1630 
pancreatic cancer patients) and found that pain, fatigue, and appetite loss were primary 
and intense symptoms experienced by patients with APC. Chapter three was a qualitative 
descriptive study which used content analysis to examine 37 transcripts of APC 
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patient/caregiver-provider health encounters originally collected for a larger 
communication study. This study identified ten major symptom groups often described as 
intense, distressing, and negatively impacting their quality of life. For chapter four, 
thematic analysis was used to examine 37 transcripts of APC/giver and provider 
interactions to develop a typology to describe patterns of interactions in regards to 
symptoms and symptom management. Eight common patient/caregiver-provider 
interaction patterns regarding symptoms and symptom management were identified. 
These typologies can be used to enhance patient/caregiver and provider communication 
programs to promote patient-centered care and improve symptom management in patients 
with APC. Findings overall will contribute to effective symptom management as it will 
deepen our understanding of symptom experience and communication processes. 
 
Diane Von Ah, PhD, RN, FAAN, Chair 
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CHAPTER ONE 
The chapter provides the background and discussion of the research, “The 
Symptom Experience of Patients with Advanced Pancreatic Cancer: An Integrative 
Review”, “Symptom Experiences in Patients with Advanced Pancreatic Cancer as 
Reported During Healthcare Encounters”, and “Patterns of Interactions Among Patients 
with Advanced Pancreatic Cancer, Their Caregivers, and Healthcare Providers During 
Symptom Discussions.” 
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Background and Significance 
Pancreatic cancer is one of the most challenging types of cancer because there are 
no effective prevention strategies, early detection methods, or promising treatments. 
Pancreatic cancer is the fourth ranked cause of cancer death among adults in the United 
States with 40,560 estimated deaths for 2015.1-1 The death rate of pancreatic cancer has 
increased slowly over the past decade despite the significant improvement in survival 
rates for most other types of cancer. Scientists predict that by 2030, pancreatic cancer will 
be the second leading cause of cancer death in the US.11-2 The majority of patients are 
diagnosed with advanced stage disease, and the overall five-year survival rate for most 
patients with advanced pancreatic cancer (APC) is only 2%.1-1, 1-3  
Symptoms are self-perceived indicators of change in normal functioning.1-4 
Effective symptom management is imperative for patients with APC due to their limited 
life expectancy, complicated treatment regimes, rapid physical deterioration, and the 
debilitating nature of some of the symptoms.1-1, 1-3 Poorly managed symptoms have been 
shown to interfere with functioning, health-related quality of life, a good death, and 
decision-making at the end-of-life in cancer population.1-4-1-7 Moreover, failure to manage 
one symptom can exacerbate others.1-8, 1-9 For example, poorly controlled pain can 
negatively affect mood and cognitive functioning.1-10 In addition, poorly managed 
symptoms can lead to unbearable suffering, which is a contributing factor of patients’ 
wishes for a hastened death.1-11, 1-12 Poor symptom management can affect caregiver 
outcomes as well. One study indicated that high symptom burden in advanced cancer 
patients can predict poor health status in caregivers.1-13 
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Patients with APC often experience distressing physical symptoms that are 
unrecognized and/or poorly managed by healthcare providers.1-14-1-18 In addition, these 
patients experience more psychological distress than persons with other types of cancer.1-
19-1-21 Although some studies have addressed symptoms associated with other terminal 
cancer populations, such as leukemia, lung, and ovarian cancer,1-22, 1-23 little is known 
about the symptom experiences of patients with APC.   
Effective symptom management is one of the critical outcomes of effective 
communication between cancer patients, their caregivers, and their providers. 1-6, 1-24-1-26 
Patient-centered communication occurs when providers elicit, show understanding of, or 
validate the perspectives of patients and caregivers. This communication can improve 
symptom experiences by encouraging expression of feelings and concerns related to the 
symptoms, assessing symptoms fully, providing support, and enhancing symptom self-
management. 1-6, 1-27, 1-28  
Evidence suggests that there are a number of barriers to effective symptom 
discussions in healthcare encounters. 1-28-1-31 For example, a qualitative content analysis 
that explored how cancer patients discuss their pain with their providers revealed that 
providers asked predominately close-ended questions and frequent interrupted patients. 1-
30 In another study of patients with APC, oncologists often finished the sentences of 
patients who were describing their symptoms, added personal opinions, ignored the 
patients’ descriptions of symptoms, and started new topics. 1-32 Some studies have shown 
that cancer patients do not always receive symptom management recommendations from 
healthcare providers. 1-28, 1-33 Patient-related barriers to symptom discussions in cancer 
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populations, such as low motivation for discussing significant symptoms with healthcare 
providers, have also been identified. 1-28, 1-31, 1-34  
Purpose and Aims 
Effective patient-provider communication, therefore, is critical to effective 
symptom management in patients with APC. More information is need, however, on how 
patients and caregivers experience symptoms and how symptom experiences in this 
population are discussed in healthcare encounters. The purpose of this dissertation is to 
advance the sciences of nursing, symptom management, and patient/caregiver and 
provider communication in patients with APC. The specific aims of this research are to 
(1) synthesize current evidence regarding symptom experience of patients with APC, (2) 
examine recorded healthcare encounters between patients with APC, their caregivers, and 
healthcare providers to better understand the symptom experiences of patients with APC 
as told to their healthcare providers, and (3) develop a typology to describe patterns of 
interactions between patients with APC, their caregivers, and healthcare providers in 
regards to symptoms and symptom management. This dissertation thus addresses two 
global research priorities in Cancer and Palliative Care: symptom management and 
communication. 1-35-1-41 
Guiding Theoretical Frameworks 
Several theories inform this dissertation project by providing a foundational 
understanding of symptom experiences and communication processes such as those that 
occur between patients with APC, caregivers, and providers. These theories include the 
Symptom Management Theory (SMT), 1-42 Armstrong’s modification of the Theory of 
Unpleasant Symptoms (mTOUS), 1-4 the Dual Process Theory of Supportive Message 
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Outcomes (DPT), 1-27 and the Conceptual Model of Communication and Health 
Outcomes (CMC). 1-6   
The SMT 1-42 and the mTOUS 1-4 indicate that symptom experiences are subjective 
perceptions, evaluations, and responses to changes in normal functioning. It is a 
multidimensional concept that includes the following aspects:  duration, intensity , 
distress, and quality and are often related to a several short-term and long-term patient 
and family outcomes. 1-4, 1-5 These outcomes are morbidity, comorbidity, mortality, 
physical and cognitive functioning, emotional status, self-care ability, quality of life, and 
costs. 1-4, 1-42 The mTOUS informed the review and synthesis of the literature presented in 
Chapter 2.   
The DPT1-27 and CMC1-6 indicate that (a) communication is carried out not only to 
exchange information but also to fulfill multiple goals, (b) a number factors can affect 
communication among patients, families, and healthcare providers such as demographic 
characteristics, past experiences, or the psychological status of the participants, 1-6, 1-27, 1-43 
and (c) the quality of communication is closely linked to patient-centeredness.6 In 
particular, the DTP indicates that the quality of a message given by a provider can be 
low, moderate, or high in person-centeredness. Messages that are low in person-
centeredness ignore or criticize patients’ feelings. Messages that are moderate in person-
centeredness acknowledge the patients’ emotions but do not allow further discussion or 
offer help to manage the emotions. Messages that are high in person-centeredness 
identify the patients’ emotions, encourage expression of the emotions, and respond to 
these emotions. 1-44  
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In this research, therefore, we conceptualize symptoms as the patients’ and 
caregivers’ personal and complex responses to changes in the patients’ normal 
functioning. We are especially interested in how patients and caregivers describe 
symptom experiences from their own perspectives. When exploring interactions in 
healthcare encounters that focus on symptom experiences, we are particularly attuned to 
the extent to which these encounters are patient-centered and to factors that influence 
whether the interactions facilitate or hinder discussion of symptom experiences.   
Dissertation Sub-studies 
This dissertation is composed of three sub-studies, each of which addresses one of 
the three aims. Each sub-study is described below.   
Sub-study 1  
To address Aim 1, an integrative literature review was conducted according to 
Whittemore and Knafl. 1-45 The purpose of this sub-study was to synthesize current 
evidence regarding APC patients’ symptom experiences.1-46 The methods and the 
findings of this sub-study appear in Chapter 2 of this document.  
Sub-study 2  
To address Aim 2, a qualitative description study as described by Sandelowski was 
conducted. 1-47 The purpose of this sub-study was to examine recorded healthcare 
encounters between patients with APC, their caregivers, and healthcare providers to 
better understand the symptom experience of patients with APC as told to their healthcare 
providers.  The methods and the findings of this sub-study appear in Chapter 3 of this 
document.  
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Sub-study 3  
To address Aim 3, a thematic analysis as described by Braun and Clarke was 
conducted. 1-48 The purpose of this sub-study was to develop a typology to describe 
patterns of interactions between patients with APC, their caregivers, and healthcare 
providers in regards to symptoms and symptom management. The methods and the 
findings of this sub-study appear in Chapter 4 of this document.  
Because the data for Aims 2 and 3 were drawn from a larger study of a 
communication intervention that produced verbatim transcripts of healthcare encounters 
between patients with APC, their caregivers, and their healthcare providers, this study 
(referred to as the parent study) is discussed below.  
Parent Study: The Values and Options in Cancer Care (VOICE) 
Purpose 
The primary goal of the VOICE study (National Cancer Institute, R01CA140419, 
Clinical Trials Identifier: NCT01485627, dual-PIs: Ronald Epstein and Richard Kravitz) 
was to test an intervention designed to facilitate communication and decision-making 
among oncologists, patients with advanced cancer, and their caregivers. The specific 
hypotheses of VOICE are that, relative to care-as-usual, the intervention will (1) improve 
physician-patient-caregiver communication about prognosis and treatment choices, 
improve the physician-patient relationship, and increase shared understanding of the 
patient’s prognosis; (2) improve patient well-being; and (3) affect health services 
utilization by both reducing the number of aggressive interventions that may undermine 
the quality of life in the last weeks of life and increasing the use of guideline concordant 
palliative care and hospice services. 1-49 
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Design 
The study was a cluster randomized controlled trial in which oncologists were 
randomly assigned to an intervention or control condition. Patients of oncologists in the 
intervention condition were assigned to the intervention group, and patients of 
oncologists in the control condition were assigned to the control group. Participants were 
requested to complete questionnaires at several time points (i.e., at study entry, after 
office visits, 2-4 days after office visits, and every 3 months for up to 3 years or until 
death) and participate in training (for the intervention arm). Participating patients and 
their caregivers, when available, were required to provide one audio-recorded office visit 
with their oncologist before and after the intervention.  
The intervention for oncologists is a multifaceted, tailored educational intervention 
involving standardized patient instructors. Patients and caregivers who were chosen in a 
randomized manner for the intervention participated in a one-hour coaching session to 
facilitate prioritizing and discussing questions and concerns. The detailed recruiting 
process and study methods were described elsewhere. 1-49  
Recruitment procedures  
VOICE recruited patients with stage three or four solid tumor cancers, caregivers 
and their oncologists from multiple oncology practices and cancer centers in the 
Rochester/Buffalo, NY and Sacramento, CA regions (2013—2015). The inclusion criteria 
for oncologists included the following: (1) were currently in clinical practice at 
participating institutions, (2) cared for patients with solid tumors, and (3) did not plan to 
leave the practice during the next 6 months. Patients were recruited if they were (1) 
currently a patient of an enrolled oncologist, (2) age 21 years or older, (3) diagnosed with 
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Stage III or IV solid (non-hematological) cancer, and 4) able to understand spoken 
English. VOICE excluded patients who anticipated bone marrow transplantation, were 
diagnosed with leukemia or lymphoma, or were hospitalized or in hospice care at 
recruitment or for baseline measures. The caregivers were recruited if they were (1) 
caregivers of a patient currently enrolled in the study, (2) age 21 years or older, and (3) 
able to understand spoken English. VOICE excluded caregivers who supported the 
patient primarily through a professional role (e.g., clergy). Ethical approval was obtained 
from the IRBs of the five affiliated institutions where the study was being conducted. All 
participants (i.e., patients, caregivers, and oncologists) completed written informed 
consent documents. A total of 383 patients and 276 caregivers participated in the VOICE. 
Table 1-1 shows the demographic data of all patients who participated in the parent study 
(VOICE). The transcripts of the audio-recorded office visits from the VOICE study 
recorded before the intervention were used in this dissertation research.  
For the current research, the transcripts of encounters that involved patients with 
APC were stored in the secure space at Purdue University and were accessed remotely 
through Virtual Private Network (VPN) or through Purdue campus network with 
assigned username and password.  Most encounters contained three participants: a 
healthcare provider, a patient, and a caregiver; 117 participants contributed to 37 
transcripts. Among the participating caregivers (n=34), 38.24% were wives, 23.53% were 
husbands, and 14.71% were daughters. The majority of the healthcare providers were 
male (n=35, 76.09%). Table 1-2 shows the demographic characteristics of the APC 
patients whose data was used for this research.  
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Institutional Review and Approval 
Prior to beginning this research, the Indiana University Human Subjects Office 
confirmed the study was an exempt study as private, identifiable information was not 
accessible and only de-identified transcripts from the VOICE study were provided.  
Trustworthiness of the Dissertation Research 
To ensure the quality of research, four standards outlined by Miles and colleagues 
(2013) served as an evaluative framework. The standards are confirmability, reliability, 
credibility, and transferability.  
Confirmability is the extent to which the findings of the research studies that 
comprised the dissertation were neutral, that is free of researcher bias, and thus can be 
confirmed by others. The strategies that were used to ensure confirmability include the 
following: 1) The study processes, especially the analysis plans, were explicitly described 
and documented, and 2) The dissertation chair and select dissertation committee members 
monitored the analytic processes and confirmed the findings presented in each sub-study 
by reviewing all the existing literature (sub-study 1) and transcript data (sub-study 2 and 
3). Many of the analytic and methodological decisions were made by group discussion 
and consensus.  
Reliability is whether the study processes remains consistent and stable over time 
and across researchers. Reliability is based on whether the researcher has taken care to 
ensure the quality and integrity of the research process. The strategies that were used to 
ensure reliability for each component were as follows: (1) Clear study aims were 
established and the study designs were explicit and consistent with each aim, and (2) The 
researcher’s dissertation committee chair, Dr. Von Ah, and other select dissertation 
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committee members ensured that all study procedures as outlined in this proposal were 
closely followed.  
Credibility is the “truth value” of the findings – that is whether the study findings 
are authentic and thus make sense to people we study and to readers. To ensure 
credibility, we obtained feedback on all codes and categories as they emerged from 
members of the Behavioral Cooperative Oncology Group (BCOG) and dissertation 
committee members. BCOG members include interdisciplinary PhD students and post-
doctoral fellows whose research interest is related to behavioral oncology. BCOG meets 
regularly to discuss research-related issues.  
Transferability is whether the study results can be generalized or transferred to 
other contexts, populations, or settings. 1-50 Transferability was ensured in this study 
through a full description of the sample from the parent study (Sub-study 2 and 3) so that 
readers can determine the extent to which the findings can apply to their own practices.  
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Table 1-1. 
Demographic Characteristics of the Participated Patients of the VOICE Study 
 
 n % (mean) 
All 383 100 
Age  382 63.5 
Race   
Non-white  41 10.70 
White  342 89.30 
Site   
UC Davis Cancer Center 136 35.51 
University of Rochester Medical Center 247 64.49 
Education    
High school or less 110 28.72 
Some college or more 273 71.28 
Gender   
Male 172 44.91 
Female 211 55.09 
Income   
Missing  45 11.75 
20,000 or less 71 18.54 
20,001-50,000 109 28.46 
50,001-100,000 111 28.98 
Over 100,000 47 12.27 
Marital status   
Missing  2 0.52 
Committed/ married 250 65.27 
Divorced/ separated 69 18.02 
Never married 26 6.79 
Widowed  36 9.40 
Insurance   
Private  151 39.43 
Medicare  198 51.70 
Medicaid/medical  29 7.57 
Other  5 1.31 
Religion    
Christianity  274 71.54 
Other  35 9.14 
No religion  74 19.32 
Have consented caregiver    
No  107 27.94 
Yes  276 72.06 
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Table 1-2. 
Demographic Characteristics of the Participated Advanced Pancreatic Patients of the 
Current Study 
 
 n % 
Participated patients 37 100 
Gender   
Female 21 56.76 
Male 16 43.24 
Participated Caregivers 34 91.89 
Caregiver Roles    
Husband 8 23.53* 
Wife 13 38.24* 
Mother 1 2.94* 
Daughter 5 14.71* 
Son  1 2.94* 
Brother  1 2.94* 
Sister 2 5.88* 
Friends  3 8.82* 
Participated Healthcare Providers 46 100** 
Oncologist 37 80.43** 
Nurse 9 19.57** 
Provider’s Gender    
Female 11 23.91** 
Male 35 76.09** 
Note. * Among all participated caregivers for advanced pancreatic cancer patients 
(n=34) 
** Among all participated healthcare providers 
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CHAPTER TWO 
This chapter describes sub-study 1 which focused on the state of the science of 
the symptom experience of patients with APC (dissertation aim 1). This sub-study 
serves as a call to action for further research, especially qualitative study, to understand 
the symptom experience of patients with APC.  
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The Symptom Experience of Patients with Advanced Pancreatic Cancer: An 
Integrative Review2-1 
Pancreatic cancer is one of the most challenging types of cancer because there are 
no effective prevention or early detection methods and treatment options are limited. 
Pancreatic cancer ranks fourth as a cause of cancer deaths, with over 40,500 estimated 
deaths for 2015 in the United States.2-2 By 2030, scientists predict that pancreatic cancer 
will be the second leading cause of cancer death. 2-3 Despite significant improvement in 
survival rates for many types of cancer, the death rate for pancreatic cancer has slowly 
increased over the past decade. In fact, the overall five-year survival rate for patients in 
the advanced stage is approximately only 2%.2-2, 2-4  
The complexity of the disease and treatment and the rapid physical deterioration 
pose special challenges to symptom management for patients with advanced pancreatic 
cancer (APC). Symptoms, which are the “perceived indicators of change in normal 
functioning as experienced by patients,” 2-5(pp68) may be both complex and severe and 
significantly impact health related quality of life (HRQOL). For patients with APC and 
their caregivers, symptom management is the primary goal of care. Yet, though some 
studies have begun to focus on special symptoms or symptom clusters among different 
critically ill cancer populations, such as leukemia and lung and ovarian cancer, 2-6-2-8 little 
is known about the symptom experience of patients living with APC. Emphasis has been 
placed on developing or evaluating treatment methods rather than symptom management.  
There is a lack of comprehensive and systematic approaches to understanding 
symptoms and their impact in patients with APC. This knowledge gap not only 
contributes to poor symptom management but also ignores how symptoms interfere with 
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patients’ survival duration, HRQOL, psychological health, communication, decision 
making, and preparing for death. 2-5, 2-9 Furthermore, because of the quick disease 
progression and terminal stage, APC is an ideal prototype to understand symptom 
changes and care needs in patients who face rapid transition from healthy status to 
terminal illness. 2-10, 2-11 Therefore, the purpose of this integrative review was to 
synthesize current evidence regarding APC patients’ symptom experiences. Findings 
from this review will inform future research directions and help health care providers 
design comfort measures that support patients as they manage and cope with symptoms. 
Methods 
This integrative review was designed to fully examine the symptoms experienced 
by patients with APC and used the methodological strategies proposed by Whittemore 
and Knafl (2005). 2-12 An integrative review was selected because it allowed us to include 
heterogeneous resources such as different research methods and varying data collection 
instruments.  The steps of the review included 1) problem identification, 2) literature 
search, 3) data evaluation, 4) data analysis, and 5) presentation of findings.       
Literature Search  
Literature describing the symptom experience of patients with APC was identified 
by searching in four databases: Pubmed, Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), Embase, and PsychINFO. We used two medical subject heading 
searches to find citations in Pubmed: 1) “pancreatic neoplasms” AND “symptom 
assessment” OR quality of life” and 2) “pancreatic neoplasms,” “signs and symptoms,” 
AND “terminal care.” The CINAHL headings of “pancreatic neoplasms” AND 
“symptoms” OR “quality of life” were used to search in the CINAHL, and the Emtree 
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terms of “pancreas cancer,” “terminally ill patients,” AND “symptoms” OR “quality of 
life” were used to search in Embase. Emtree terms are hierarchically structured 
terminologies which are used to index the Embase content. For PsychINFO, subject terms 
of "neoplasms," "pancreas," AND "symptoms” OR “quality of life" were used. In 
addition to subject terms, we also used key words (i.e., “pancreatic cancer” AND “stage 
three” OR “stage four” OR terminal OR palliative) AND (symptoms OR signs OR 
“quality of life”)) to search aforementioned databases. Search limitations were English 
language, human sample, and year published (2005-2015) since treatment protocols for 
APC advance quickly. Each journal article’s reference list was also carefully searched by 
hand to identify additional pertinent articles. The search results were imported into 
EndNote X7.5 and duplicates were removed. We then reviewed the titles, abstracts, and 
full text of the articles based on the inclusion and exclusion criteria to determine their 
eligibility.     
Inclusion and exclusion criteria. Based on the theoretical definition of symptom 
experience in Armstrong’s concept analysis and Lenz’s Theory of Unpleasant Symptoms, 
only the patient can report on the symptom experience, including its four dimensions: 
intensity, timing, quality, and distress. 2-5, 2-13 Therefore, manuscripts included in this 
review include quantitative, qualitative, and mixed-methods studies focusing on physical 
or psychological symptoms experienced and reported by patients with APC.  APC 
patients were defined as patients diagnosed with locally advanced or distant pancreatic 
cancer that was not eligible for curative surgery at diagnosis. We also included studies 
with heterogeneous cancer patient populations only if the results for those with APC were 
analyzed separately. 
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We excluded manuscripts that: (1) did not report on empirical studies, including 
opinions, case reports, or editorials; (2) were review articles; (3) did not include patient 
“self-report” of symptoms; or (4) only addressed symptoms related to a specific drug or 
procedure because the foci of these articles were on drug toxicity or safety/effectiveness 
of the procedure versus overall symptom experiences. Moreover, studies focused only on 
specific drug- or procedure-related symptoms often set inclusion criteria of particular 
symptom intensity (e.g., patients with moderate pain).  
Data Extraction   
We used an author-developed data coding sheet to conduct the two steps of data 
extraction. First, we extracted information regarding authors, year of publication, setting 
characteristics, participant characteristics, and study design. Second, we extracted 
information with regard to symptom-related variables based on the aforementioned 
concept analysis and theoretical framework. Third, the symptom-related variables, 
including type of symptom, measurement instruments, symptom profile (symptom 
intensity, timing, quality, and distress), and associated factors were identified. The four 
dimensions of symptom profile were defined based on the Theory of Unpleasant 
Symptoms. 2-5 Specifically, symptom quality is related to characteristics of symptoms 
(e.g., “burning” pain). Symptom intensity quantifies the degree, strength, or severity of 
symptoms. Timing is related to the occurring time, duration, and frequency. The distress 
dimension refers to the affective aspect or meaning of symptoms. 2-5 After reading the 
articles, two of the authors (C. T. & D. V.) highlighted relevant information and 
organized information using the coding sheet. We further created several tables to 
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contrast and compare variables. Tables are presented along with findings in the next 
paragraph.  
Findings 
Nine hundred and sixteen articles were initially identified. After removing 
duplicates (n=90), the remaining 826 articles were screened by titles, which resulted in a 
total of 337 articles remaining. After screening the 337 abstracts using the established 
criteria, 293 articles were excluded. Among the 293 articles, 44% (n=128) did not report 
results specific to an APC population; 36 % (n=106) were non-empirical, non-peer-
reviewed, or review articles; 16% (n=47) did not include patient-reported symptoms; and 
4% (n=12) only addressed symptoms related to a specific drug or procedure. Among the 
44 articles that were retained for full-text review, 29 were excluded because they (1) did 
not include patient-reported symptoms (n=11), (2) only addressed symptoms related to a 
specific drug or procedure (n=11), (3) did not report results specific to an APC 
population (n=6); and/or (4) were not written in English (n=1). A hand search of each 
manuscript’s reference list resulted in adding one more article. Thus, a total of 16 studies 
was included in the analysis (Figure 2-1).  
All 16 studies were quantitative, with five descriptive studies, 2-14-2-18 four 
correlational studies, 2-19-2-22 and seven quasi-experimental studies. 2-23-2-29 Six of the 16 
studies (37.5%) explored overall symptom experiences or the relationship among 
symptoms in patients with APC, 2-16, 2-18-2-22 and two studies (12.5%) compared symptom 
experiences across different pancreatic cancer stages. 2-14, 2-17 Five studies (31.25%) 
focused on pain or pain management strategies for patients with APC, 2-15, 2-23, 2-24, 2-28, 2-29 
and the remaining three studies (18.75%) focused on interventions other than pain 
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management. 2-25-2-27 Only 2 of the 16 studies explicitly described a guiding theory or 
framework. The theoretical frameworks utilized were systematic inflammation2-18 and 
descriptions of nociceptive and neuropathic pain. 2-15 The number of study participants 
ranged from 20 to 654, and the APC patients’ medium survival duration for those articles 
that reported on this variable (n=8) was about 6.36 months (range from 3.5 to 8.9 
months). About half (n=8) of the studies were conducted in Europe2-16, 2-18, 2-19, 2-22-2-25, 2-27 
and the other half in North America (n=7). 2-14, 2-15, 2-17, 2-20, 2-21, 2-26, 2-28 One study was 
conducted in Asia. 2-29 Table 2-1 displays study aims, designs, population, and symptom-
related results. From our review, we organized the studies by symptom types and 
instruments, symptoms identified, symptom profiles, and factors associated with 
symptoms.  
Instruments  
All studies used instruments to evaluate pre-determined symptoms. The 9 
instruments used in the 16 studies were in two categories: one focused on evaluating 
cancer patients’ multiple symptoms and HRQOL and the other focused solely on pain. 
Six instruments that focus on multiple symptoms are the European Organization for 
Research and Treatment of Cancer (EORCT QLQ-C30) with or without the pancreatic 
special module (EORCT QLQ-PAN26), the Edmonton Symptom Assessment Scale 
(ESAS), the European Quality of Life-5 Dimensions (EQ-5D), the Functional 
Assessment of Cancer Therapy general module (FACT-G) with or without the 
hepatobiliary module (FACT-HEP), the Linear Analog Scale Assessment (LASA), and 
the M.D. Anderson Symptom Inventory (MDASI). Table 2-2 displays the symptom 
inventory captured by these six instruments. Three instruments focused solely on pain are 
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the McGill Melzack Pain Questionnaire, 2-15 the Brief Pain Inventory (BPI), 2-23 and a 
single item for rating pain intensity and frequency. 2-25 Overall, the EORTC QLQ-C30 
and/or EORTC QLQ-PAN26 were the most frequently used measurement tools (n=8), 2-
14, 2-16, 2-18, 2-19, 2-21, 2-24, 2-27, 2-28 followed by the FACT-G (n=2). 2-17, 2-23 Though 
investigators used a variety of different instruments to measure symptoms, some 
symptoms are included in instruments more often than others. Specifically, almost all 
symptom evaluation instruments measured pain and depression symptoms. However, 
taste change, numbness, and most psychological symptoms were addressed by only one 
or two instruments.  
Symptoms Identified 
All studies identified physical symptoms, and nine of the 16 (56.25%) studies2-14, 2-
16, 2-18-2-20, 2-22-2-24, 2-26 also covered psychological symptoms. Table 2-3 shows authors, the 
symptoms reviewed, and measurement instruments. Importantly, Table 2-3 also displays 
the problematic symptoms identified by each study and the corresponding operational 
definitions of problematic symptoms. The physical symptoms identified in the APC 
samples were pain, fatigue/lack of energy, loss of appetite, dry mouth, taste change, 
digestive problems (e.g., nausea, vomiting, altered bowel habits, indigestion, and 
flatulence), respiratory problems (e.g., dyspnea), and poor sleep. The psychological 
symptoms were related to sense of well-being, anxiety, depression/sadness, emotional 
distress/mood disturbance, life enjoyment, and fear. Congruent with our previous 
observation that all instruments measured pain, pain was the most prevalent symptom 
discussed in all studies, followed by fatigue (n=11, 68.75%), digestive symptoms (n=9, 
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56.25%), and loss of appetite (n=7, 43.75%). However, although depression was also 
included in most instruments used, it was only discussed in six (37.5%) of the studies.   
Symptom Profile: Intensity, Timing, Quality, and Distress  
In this section, we report APC patients’ symptom profiles using the Theory of 
Unpleasant Symptoms’ four dimensions: intensity, timing, quality, and distress. The 
majority of the studies found that patients with APC had substantial physical and 
psychological symptoms, especially as related to the intensity dimension. 2-14, 2-16-2-29 
Compared to the healthy population and early stage pancreatic cancer population, patients 
with APC reported more total symptoms and more intense symptoms such as fatigue, 
appetite loss, pain, digestive symptoms (e.g., indigestion), anxiety, and depression. 2-14, 2-
16, 2-17, 2-26 Although the researchers used various instruments with different operational 
definitions to determine the level of intensity of symptoms, they reported that a 
considerable number (more than 25%) of patients experienced moderate to severe 
intensity of symptoms that included fatigue, 2-16, 2-19-2-21, 2-27-2-29 loss of appetite, 2-16, 2-19-2-
21, 2-27-2-29 pain, 2-14, 2-16, 2-20, 2-21, 2-25-2-28 insomnia, 2-21, 2-27-2-29 digestive symptoms, 2-14, 2-27-2-
29 impaired sense of well-being, 2-16, 2-19 anxiety and depression, 2-26 and fear. 2-14 Fatigue, 
loss of appetite, and pain were the top three severe symptoms reported.  
Eleven studies explored fatigue, and most of these reported patients’ average 
fatigue intensity was moderate to severe. 2-16, 2-19-2-21, 2-27-2-29,  In those articles that 
provided more specific information, 19% to 63% patients experienced moderate to severe 
fatigue. 2-16, 2-18-2-20 Similarly, studies examining loss of appetite (n=7) reported the 
average intensity of appetite loss was moderate to severe, 2-16, 2-19-2-21, 2-27-2-29 with about 
24% to 63% of patients in those articles giving that information having loss of appetite 
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that was moderate to severe. 2-16, 2-19, 2-20 With regard to pain, patients experienced 
moderate to severe pain on average regardless of treatment types or disease progression. 
2-14, 2-16, 2-21, 2-27 Specifically, 15%-43% of patients with APC reported moderate to severe 
pain. 2-18-2-20, 2-25 Symptom intensity changed along with treatment and disease progress. 
Though pain2-21, 2-28, 2-29 and insomnia2-21, 2-28, 2-29 improved significantly after treatments 
(e.g., celiac plexus block surgery), the intensity of several physical symptoms including 
fatigue, 2-29 digestive symptoms, 2-16, 2-19, 2-27, 2-29 dyspnea2-16, and dry mouth2-16 worsened 
with general care, palliative resection, or celiac plexus block surgery. For loss of appetite, 
some studies found a significant improvement after celiac plexus block surgery; 2-28, 2-29 
and other studies demonstrated that the symptom got worse with general care and 
palliative bypass surgery. 2-21, 2-27   
Among the studies reporting psychological symptoms (n=9), the focus was on 
sense of well-being, 2-16, 2-19, 2-24 depression, 2-16, 2-18-2-20, 2-23, 2-26 and anxiety. 2-16, 2-19, 2-30 
Two studies found that patients with APC experienced moderate to severe impairment in 
their sense of well-being, which worsened as the disease progressed. 2-16, 2-19 Studies 
presented contradictory findings regarding depression. Some showed that most patients 
experienced mild depression, with mean intensity scores of 2 to 3 out of 10, 2-16, 2-20 
whereas others showed that about 40% of patients experienced moderate to severe 
depression. 2-18, 2-19 Similarly, Bye and colleagues (2013) found that 37-44% patients 
experienced moderate to severe intensity of anxiety, although the mean intensity score for 
anxiety reported by Labori et al. (2006) was at a mild level. Regardless of the intensity 
level, Romanus et al. (2012) reported that more than half of the patients experienced 
anxiety and depression. When the disease progressed, the intensity of anxiety and 
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depression stayed the same or slightly increased. 2-16, 2-19 Most studies used EORTC QLQ-
C30 to measure anxiety and depression. 2-16, 2-18, 2-19 
Three studies examined the timing dimension of the symptoms, including 
frequencies2-25 and possible coexisting symptoms or symptom clusters. 2-18, 2-20 Muller et 
al. (2008) reported that 51% of the patients with APC had daily pain. For the coexisting 
symptoms, Reyes-Gibby et al. (2007) reported all possible symptoms, but Laird and 
colleagues (2011) focused on the common symptom cluster of pain, fatigue, and 
depression in cancer patients. These two studies found that about 24% to 51% of the 
patients had two or more coexisting symptoms with moderate to severe levels of 
intensity. The proportion of patients with such symptoms tended to increase temporarily 
during chemoradiation. 2-20 Specifically, researchers identified two possible symptom 
clusters. Laird et al. reported more than double the number of patients who would have 
been expected to have had the symptom combination of pain, fatigue, and depression if 
the symptoms were to coexist by chance. Reyes-Gibby et al. (2007) reported a strong 
relationship between fatigue and loss of appetite.  Only one study explored how patients 
described their symptom quality verbally. 2-15 With a very small sample size, Dobratz 
(2008) could not distinguish pain patterns (e.g., nociceptive vs. neuropathic pain) based 
on APC patients’ word choices. No study explored the distress dimension of the 
symptoms.  
 Factors Associated with Symptoms 
A number of factors were noted to play into APC patients’ symptom experiences. 
Researchers found that fatigue, loss of appetite, pain, and mood were significantly 
associated with other factors such as comorbidity, mortality, function or performance 
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level, energy intake, psychological status, HRQOL, social relationships, and survival 
duration. Specifically, fatigue was negatively associated with energy intake and predicted 
the interference levels of walking, activity, work, enjoyment of life, and survival. 2-19, 2-20, 
2-22 Loss of appetite was not only linked to physical function such as energy intake, 
walking, and activity, but it also predicted psychological function including mood and 
enjoyment of life. 2-19, 2-20 Pain was negatively related to performance, energy intake, and 
relationships with other people. 2-19, 2-20, 2-22, 2-23 One study further indicated that pain 
intensity can predict survival in patients receiving chemotherapy. In this study, 
researchers also found that poor performance was associated with impaired mood. 2-22 
Low energy intake and complex comorbid medical conditions were linked to higher 
overall symptom intensity. 2-19, 2-20  
Discussion 
The purpose of this review was to synthesize current evidence regarding APC 
patients’ symptom experiences. Based on the 16 reviewed studies, all using a quantitative 
approach with a pre-determined symptom inventory, our main findings were that patients 
with APC experienced multiple intense physical symptoms, especially fatigue, loss of 
appetite, and pain. With limited and inconsistent study results, APC patients’ experiences 
regarding psychological symptoms remains unclear. Similarly, evidence of coexisting 
symptoms or symptom clusters in the APC population is limited. However, current 
evidence suggests that coexisting symptoms exist. Although there is no qualitative study 
met our inclusion criteria, qualitative evidence supported one of our main findings: 
patients with APC incur a number of complex symptoms that can become debilitating. 
Qualitative studies exploring terminal pancreatic cancer patients’ concerns showed that 
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patients and their caregivers experienced several symptoms and expressed their great 
concerns about both physical and psychological symptoms. 2-31, 2-32 The following 
paragraphs further discuss findings in depth with several identified knowledge gaps. 
 First, the use of various symptom measurement instruments makes it difficult to 
compare identified symptoms and symptom intensity across studies. Instrument variation 
is especially problematic when interpreting psychological symptoms because every 
instrument uses different terms and definitions in relation to psychological symptoms 
(e.g., depression and sadness). Instruments such as LASA measure psychological 
symptoms using one general term (i.e., mood) to capture patients’ experience with regard 
to depression, anxiety, and stress. Furthermore, all reviewed studies only focused on 
intensity dimension of predetermined symptoms because of forced-choice instruments 
and might ignore other symptoms and other symptom dimensions such as quality and 
distress. Another problem with regard to the instrument is that using the instruments 
designed to measure HRQOL to evaluate symptoms, as most of our reviewed articles did, 
causes difficulties in understanding and managing nutrition-related symptoms. 2-33  
Second, although our results show that fatigue, loss of appetite, and pain were 
prevalent and intense physical symptoms reported by the patients across studies, these 
symptoms received disproportionate attention. It is not surprising that pain has been the 
major focus of studies since pancreatic cancer is widely known to be one of the most 
painful malignancies. 2-34 All reviewed studies addressed pain and about half of them 
focused on pain management strategies. In contrast, only half or fewer of the studies 
mentioned other problematic physical symptoms (e.g., fatigue or loss of appetite) and 
their symptom management strategies. Our review found that fatigue is a prominent and 
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severe problem in the APC population, which corresponds to existing assumptions in all 
cancer population. 2-35 On the other hand, there is a growing recognition that loss of 
appetite is one of the most distressing symptoms for APC and their caregivers, but is 
often overlooked by health care professionals. 2-36-2-38 Although the etiology of loss of 
appetite is multifactorial and not fully understood, the experience and management of 
loss of appetite can be particularly complicated for patients with APC because it may be 
associated not only with treatment and physical deterioration but also with reduced 
pancreatic function (e.g., pancreatic exocrine insufficiency) and depression, 2-19, 2-38 which 
is a prevalent symptom in this context. 2-39 The disproportion emphasis of physical 
symptoms is not only obvious in research but also observable in the clinical practice. 
Two articles which reported the most significant problems faced by health care providers 
when caring for patients with APC only discussed pain and anorexia-cachexia. 2-40, 2-41 
Other studies showed that while pain management has been noted as the most frequent 
intervention provided in the hospice consultation for patients with APC, nutrition related 
evaluation and intervention was documented in less than 15% of the charts. 2-42, 2-43 This 
ignorance of non-pain symptoms prohibits health care providers from understanding APC 
patients’ symptom profile fully and addressing their needs. A qualitative study reported 
that pancreatic cancer patients expressed their lack of knowledge, confidence, resource 
access, and effective communication with health care providers when managing their 
digestive symptoms. 2-33 Our limited understanding of these problematic symptoms may 
also partly explain why there are still no effective symptom management strategies for 
the majority of the symptoms, although APC patients experienced these intense 
symptoms until death. For example, whereas general treatments (e.g., chemotherapy) and 
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pain management surgeries (e.g., nerve block) improved pain and insomnia, fatigue and 
digestive symptoms did not change or even worsened. Studies pointed out that the severe 
symptoms continuously contribute to APC patients’ poor functional status and HRQOL 
with nutrition and digestion symptoms and fatigue being the most significant symptoms 
affecting HRQOL. 2-33, 2-42, 2-44 
Third, psychological symptoms also have received insufficient attention. Only 
about half of the studies addressed psychological symptoms, and there was little in-depth 
exploration or discussion. Our findings showed different symptom profiles of 
psychological symptoms and, because of the limited number of studies looking at these 
symptoms, cannot either support nor reject the mounting evidence of strikingly high 
psychological distress rates in pancreatic cancer population compared to other types of 
cancer. 2-39, 2-45, 2-46 For example, although two reviewed studies2-18, 2-19 found that 
depression was a severe problem, with approximately 33-50% of the pancreatic cancer 
patients experiencing depression, 2-39 other researchers2-16, 2-20 concluded that depression 
is mild in APC population. These different results may be because of different 
measurement methods (e.g., mean symptom score vs. the percent of patients with a high 
symptom score). However, our results do support that psychological distress is elevated 
when disease progresses over time. 2-47 
Despite the insufficient evidence, qualitative evidence suggested that psychological 
distress bothers APC patients and their caregivers. Researchers analyzing the types of 
questions asked by terminal pancreatic cancer patients and their caregivers online 
indicated that 11-23% of the questions were related to psychological concerns. 2-31, 2-48 
Interestingly, while maintaining hope is one of the main themes identified with regard to 
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pancreatic cancer patients’ experience, 2-49 only one instrument was used by our sample 
studies that evaluates hope. None of our sample studies addressed hope in their result or 
discussion. Although the evidence is not enough to determine the possible cause of 
psychological symptoms in pancreatic cancer, 2-50, 2-51 it is clear that there is a 
complicated relationship among patients’ physical symptoms, physical symptoms, and 
health related outcomes. A qualitative study demonstrated that nearly all patients 
expressed feelings of anger, frustration, and powerless related to the lack of knowledge of 
symptoms, unfamiliarity of symptom management strategies, and poor symptom control. 
2-33 Researchers suggested that the psychological distress is significantly related to poor 
QOL, fatigue, pain, and loss of appetite in pancreatic cancer population. 2-45   
Fourth, with only three studies exploring pain frequencies and co-existing 
symptoms, we know little about the timing dimension of the symptoms. Although our 
findings suggest that symptom clusters may exist, more evidence is needed to determine 
if there is any unique symptom cluster that is associated with APC. Lastly, we have 
almost no clues regarding the quality and distress dimension of the symptoms since only 
one article discussed pain quality and no study explored symptom distress.   
Conclusion 
To our knowledge, this is the first integrative review to explore symptom 
experiences of patients living with APC. By synthesizing the important evidence and 
highlighting the knowledge gaps, this review has important implications for both clinical 
and research practice. For clinical practice, the review findings help to target problems 
for improved symptom management in APC patients. Furthermore, we have identified 
pressing needs to raise awareness of and design interventions for a number of poorly 
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managed and severe symptoms. For future research, given that quantitative methodology 
has been the predominant approach to examine symptom experience of patients with 
APC to date, qualitative studies are needed to explore the multiple dimensions of 
symptoms.  For both researchers and clinicians, it is imperative to focus on psychological 
symptoms, which are still underexplored yet were the main concerns mentioned by 
patients and caregivers during patient-health care provider discussions. 2-48 Studying 
psychological symptoms will facilitate a deeper understanding of the high psychological 
distress rate and the causes so that interventions to alleviate this distress can be 
developed.  
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Records identified through 
database searching 
(n=382) 
Additional records 
identified through in 
reference lists (n=1) 
Records after duplicates removed 
(n=334) 
Abstract screened for eligibility 
(n=172) 
Full-text articles assessed for screened 
for eligibility  
(n=31) 
Study included in integrative review 
(n=15) 
 
Records with irrelevant titles 
(n=162) 
Records excluded (n=141) 
• Not report results specific to 
APC population: 77 
• Non-empirical, non-peer-
reviewed or review articles: 50 
•  Not include patient-reported 
symptoms: 10 
• Only addressed symptoms 
related to specific drug or 
procedure: 4 
Full-text articles excluded (n=17) 
• Not include patient-reported 
symptoms: 7 
• Only address symptoms related 
to specific drug or procedure: 5 
• Not report results specific to 
advanced pancreatic cancer 
population: 4 
• Not English:1 
Figure 2-1. PRISMA Diagram of Search Results and Screening Process 
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Table 2-1. Summary of the Reviewed Studies 
 
First author 
(year of 
publish) 
Study aim  Study design  Population 
(n=number of 
study participants) 
Symptom related results [measurement tool] 
Allen 
(2011) 
To assess the efficacy of 
laparoscopic celiac plexus 
block. 
 
Quantitative; 
quasi-
experimental 
study 
Unresectable 
pancreatic 
malignancy with 
significant pain  
Symptom intensity:  
a) Baseline: Mean pain score: 7.8/10 [BPI] and 65.8/100 [EORTC QLQ-
C30]. 
b) Follow-up:  pain, insomnia, and appetite loss improved significantly 4 
weeks after procedure [EORTC QLQ-C30]. 
Bye (2012) To assess energy intake, 
weight loss and symptoms 
during the disease course 
and investigate 
associations between 
symptoms and energy 
intake. 
Quantitative, 
descriptive 
correlational 
study  
APC (n=39) Symptom intensity:  
a) Baseline: 37% to 63% patients had moderate to severe intensity of 
almost all symptoms [ESAS]. Flatulence, oral dryness and indigestion 
were the most frequent symptoms reported [QLQ-PAN26]. 
b) Follow-up: minor changes from baseline [ESAS & QLQ-PAN26] 
Associating factors:  
c) The correlations between energy intake and symptoms become 
stronger when disease progress: At 2 month follow-up, there is strong 
negative correlation between energy intake, appetite loss, oral dryness 
and fatigue. At 3 month follow-up, there is a strong negative 
correlation between energy intake and appetite loss, pain, dyspnea and 
flatulence.  
Braun 
(2013) 
To examine if baseline 
QoL and QoL changes 
from baseline until 3 
months after treatment 
could predict survival in 
patients with stage IV 
pancreatic cancer. 
Quantitative; 
descriptive 
correlational 
study 
Stage IV pancreatic 
cancer (n=186) 
Symptom intensity:  
a) Baseline: In average, patients experienced fatigue (41.8/100), pain 
(37.6/100), insomnia (36.6/100), and appetite loss (33.3/100) at 
moderate level [EORTC QLQ-C30]. 
b) Follow-up: fatigue and appetite loss worsen; pain and insomnia 
improved 3 months after treatment.  
Associating factors:  
c) Physical function, social function, fatigue, pain, dyspnea, and global 
health were predictive of survival. 
Crippa 
(2008) 
Evaluate the QoL and 
survival in patients with 
different stages of 
pancreatic cancer  
Quantitative; 
descriptive 
longitudinal 
study 
Pancreatic cancer 
(n=92; n of APC: 
64) 
Symptom intensity:  
APC patients tended to report more abdominal pain than patients had 
localized pancreatic cancer 
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Dobratz 
(2009) 
To determine if 
nociceptive/ neuropathic 
pain could be identified 
by word selections  
Quantitative; 
descriptive 
study  
Advanced cancer 
patients received 
home-based 
hospice services 
(n=76; n of APC: 
4) 
Symptom quality: 
APC patients showed no distinct pain pattern (nociceptive or neuropathic) 
in their word choices while colon and liver cancer selected words that 
described 2 types of nociceptive (visceral, somatic) pain and prostate 
cancer patients noted somatic pain. 
Gao (2014) To evaluate the 
effectiveness of standard 
pain medication with or 
without NCPB  
Quantitative; 
quasi-
experimental 
study 
Unreseactable 
pancreatic cancer 
with pain 
Symptom intensity:  
a) Baseline: in average, patients experienced fatigue and constipation at 
moderate level; pain, insomnia, and appetite loss at severe level 
[EORTC QLQ-C30]. 
b) Follow-up: pain, appetite loss, and insomnia improved significantly 3 
month post-therapy. 
Labori 
(2006) 
To describe prospectively 
the prevalence and 
severity of disease-related 
symptoms, QoL and need 
for palliative care in 
patients with APC 
Quantitative, 
descriptive 
longitudinal 
study  
APC (n=51) Symptom intensity:  
a) Baseline: fatigue and loss of appetite have highest mean score [ESAS 
& EORTC QLQ-C30]. Compared to general population, APC 
patients’ fatigue, pain, and appetite loss were significantly impaired 
[EORTC QLQ-C30]. 
b) Follow-up: increasing intensity of all symptoms the last 8 weeks 
before death, except for pain at rest and appetite [ESAS]. 
Laird 
(2011) 
To examined whether 
pain, depression, and 
fatigue exist as a 
symptom cluster in 
advanced cancer patients 
with cachexia and might 
be related to the presence 
of systematic 
inflammation 
Quantitative; 
comparative 
descriptive 
study 
Cachectic, 
advanced, 
unresectable cancer 
(n=654; n of APC: 
181)  
Timing dimension of symptom:  
a) Pain, depression, and fatigue is an identifiable symptom cluster in a 
cohort of cachexic cancer patients. The prevalence of symptom cluster 
of pain, fatigue and depression is greater in lung and GI cancer than 
APC [EORTC QLQ-C30]. 
Associating factors: 
b) For all patients, Pain, depression, and fatigue symptom cluster was 
associated with reduced physical functioning, but not related to CRP. 
Moningi 
(2015) 
To evaluate how QoL 
change based on clinical 
stage at presentation to 
the JH Pancreas 
Multidisciplinary 
Clinic 
Quantitative; 
descriptive 
study  
Patients visited the 
Johns Hopkins 
Pancreas 
Multidisciplinary 
Clinic (n=77; n of 
APC: 39) 
Symptom intensity:  
a) APC patients had significantly worse indigestion, flatulence, and diet 
limitations than patients with non-advanced stage [EORTC QLQ-
PAN26]. 
Associating factors: 
b) Patients with lower performance status had significantly worse 
pancreatic pain and digestive symptoms. 
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Muller 
(2008) 
To evaluate a palliative 
surgical bypass procedure 
in patients with 
obstructive and 
intraoperative pancreatic 
cancer 
Quantitative; 
quasi-
experimental 
study 
Non-resectable 
pancreatic cancer 
(n=136) 
Symptom intensity:  
a) Baseline: 26% patients had moderate- to severe- pain. 
Timing dimension of symptom:  
b) Baseline: 51% patients had daily pain 
Associating factors: 
c) Daily pain associated with significant poor survival after bypass 
surgery and was a significant independent indicator of poor survival.   
Reyes-
Gibby 
(2007) 
To assess symptoms of 
patients with locally 
advanced pancreatic 
cancer receiving 
chemoradiation to 
determine the prevalence, 
and co-occurrence, of 
symptoms and to identify 
the extent to which 
symptoms interfered with 
function 
Quantitative, 
descriptive 
correlational 
study  
Locally advanced 
pancreatic cancer 
(n=43) 
 
Symptom intensity:  
a) Baseline: 95% of patients reported at least one of the 13 symptoms. 
The most commonly reported symptoms of moderate to severe 
intensity were lack of appetite (24%), pain (19%), fatigue (19%), and 
sleep disturbance (10%) [MDASI].  
b) Follow-up: An increase in patients reporting moderate to severe 
fatigue, nausea, and sleep disturbance during chemoradiation. The 
proportion of patients reporting moderate to severe symptoms of pain, 
lack of appetite, fatigue and sleep disturbance significantly decreased 
after 94 days of chemoradiation. 
Associating factors:  
c) Presence of a comorbid medical condition was a signiﬁcant factor for 
symptom intensity. Lack of appetite, fatigue, sleep, and pain were the 
symptoms that accounted for variation in walking, activity, mood and 
enjoyment of life.  
Romanus 
(2012) 
To evaluate health-related 
QoL in patients with APC 
participating in a 
multicenter, double-blind, 
randomized trial 
Quantitative; 
quasi-
experimental 
study 
Inoperable 
pancreatic cancer 
with ECOG status 
of 0-2 (n=186) 
Symptom intensity:  
a) Baseline: compared with the U.S. general population, a larger 
proportion of APC patients reported problems in pain/discomfort 
(78%) and anxiety/depression (53%) [EQ-5D]. 
b) Follow-up: symptoms of anxiety/depression and pain/discomfort 
improved. 
Seicean 
(2013) 
To evaluate the safety and 
efficacy of EUS-CPN in 
patients with painful 
unresectable pancreatic 
cancer 
Quantitative; 
quasi-
experimental 
study  
Inoperable, chemo-
naïve body-tail 
pancreatic cancer 
receiving opioid 
analgesia (n=32) 
Symptom intensity:  
a) Follow-up: pain improved significantly in 75% patients [BPI]. 
Associating factors:   
b) After procedure, ratings of “pain interfering with general activity, 
walking, work, mood, enjoyment of life, relations with others, and 
sleep” improved significantly. Physical, functional, and emotional 
well-being also improved significantly [FACT]. 
Stefaniak 
(2005) 
To compare the 
effectiveness of two 
Quantitative; 
quasi-
Inoperable Symptom intensity:  
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invasive pain treatments 
(NCPB & VSPL) to a 
control group concerning 
pain and QoL  
experimental 
study 
pancreatic cancer 
with pain 
(n=59) 
(a) Follow-up: Both methods of invasive pain treatment resulted in 
significant reduction of pain and fatigue.  
Associating factors:  (b) Physical, emotional and social well-being improved significantly only 
in NCPB group. 
Walter 
(2011) 
To compare QoL of 
patients with APC who 
were given palliative 
resection or double loop 
bypass surgery 
Quantitative; 
quasi-
experimental 
study 
APC (n=196) Symptom intensity:  (a) Baseline: the average intensity level of appetite loss, insomnia, pain, 
fatigue, dyspnea, constipation, and diarrhea is moderate. (b) Follow-up: Palliative resection group had significantly increased 
dyspnea at discharge; increased nausea, dyspnea, constipation, and 
diarrhoea at 3 months after surgery. Appetite loss was more 
aggravated in double loop bypass group at 6 months after surgery. 
 
Abbreviations: APC, advanced pancreatic cancer; ECOG, Eastern Cooperative Oncology Group performance; ESAS, Edmonton Symptom Assessment Scale; 
EORTC QLQ-C30, European Organization for Research and Treatment of Cancer core module; EORTC QLQ-PAN26, European Organization for Research 
and Treatment of Cancer pancreatic cancer module; EQ-5D, European Quality of Life-5 Dimensions; FACT, Functional Assessment of Cancer Therapy; EUS-
CPN; Endoscopic ultrasound-guided celiac plexus neurolysis; MDASI, M.D. Anderson Symptom Inventory; NCPB, neurolytic coeliac plexus block; JH, 
Johns Hopkins; VSPL, videothoracoscopic splanchnicectomy; QoL, quality of life. 
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Table 2-2. Symptoms Measured by EORTC QLQ-30/Pan26, EQ-5D, ESAS, 
FACT-G/Hep, and MDASI 
 
         
Instruments 
 
 
Symptoms 
EORTC  ESAS EQ-
5D 
FACT MDAS
I 
Core 
module 
(QLQ-30) 
 
Pancreatic 
cancer 
module 
(PAN26) 
  General 
module 
(G) 
hepatobiliar
y module 
(Hep) 
 
Pain  X X X  X  X  X  X  
Loss of appetite  X     X  X  
Fatigue/ lack of 
energy 
X  X   X  X  X  
Sleep X      X  
Respiratory X  X     X  
Oral dryness  X     X  X  
Test change   X     X   
Digestivea X X X   X  X  X  
Numbness        X  
Senses of well-
being 
  X  X    
Anxiety   X  X     
Depression/ 
sadness 
X  X  X  X   X  
Emotional 
distress/ mood 
disturbance 
      X  
Life enjoyment       X  
Fear X  X       
Worry X    X   X  
Drowsiness    X     X  
Satisfaction  X     X    
Hope      X    
 
Abbreviations: EORCT, European Organization for Research and Treatment of Cancer; ESAS, 
Edmonton Symptom Assessment Scale; EQ-5D, European Quality of Life-5 Dimensions; FACT, 
Functional Assessment of Cancer Therapy; MDASI, M.D. Anderson Symptom Inventory. 
a Digestive symptoms includes nausea and vomiting, flatulence, altered bowel movement and indigestion 
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Table 2-3.  Symptoms and Problematic Symptoms Identified by Reviewed Studies and Corresponding Instrumentsa 
 
 Bye  Labori  Braun Gao Larid  Allen Moningi Walter Stefaniak  Crippa  Seicean  Reyes-
Gibby  
Romanus Dobratz Muller 
Ph
ys
ic
al
 
Pain  X  X  X  X  X  X  X  X  X  X  X  X  X  X  X  
Loss of 
appetite  
X  X  X  X  X  X       X     
Fatigue/ 
lack of 
energy 
X  X  X X  X  X   X  X   X  X     
Sleep   X X  X  X      X  X     
Respiratory   X X  X  X       X     
Oral 
dryness 
X  X           X     
Test 
change  
X                
Digestiveb X  X  X  X  X  X  X     X  X     
Numbness             X     
Ps
yc
ho
lo
gi
ca
l 
Senses of 
well-being 
X  X        X        
Anxiety X  X            X    
Depression/ 
sadness 
X  X       X    X  X  X    
Emotional 
distress/ 
mood 
disturbance 
           X     
Life 
enjoyment 
          X      
Fear of 
future 
health 
problems 
      X          
Instruments  • EORTC QLQ-C30 & 
PAN26 
• ESAS 
EORTC QLQ-C30 
 
• EORTC 
QLQ-
C30 & 
PAN26 
• BPI 
EORTC 
QLQ-
PAN26 
EORTC 
QLQ-C30 
• EORCT 
QLQ-
C30 
• FACT-
G 
• FACT-
G 
• FACT-
Hep 
• FACT-
G 
• BPI  
MDASI EQ-5D McGill 
Melzack 
Pain 
Questio-
nnaire 
Single item 
of pain 
intensity 
and 
frequency 
Operational 
definition of 
intensity levels 
[EORTC] 
Moderate: ≥33.3; 
Severe:≥66.7 
[ESAS] 
Moderate-severe: ≥4 
[EORTC] 
Moderate: ≥33.3; Severe:≥66.7 
 
 
Pain, 
fatigue, and 
depression 
respectively: 
Moderate: ≥ 
- - [BPI] 
moderate: 
4-6; 
severe:≥7 
Moderate-
severe: ≥5 
- - - 
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50,  ≥ 60, 
≤70 
Severe: ≥60, 
≥70, ≤50 
Determination of 
the relatively 
problematic 
symptoms 
More 
than half 
reported 
moderate- 
to severe- 
intensity 
Moderate 
intensity 
on ESAS 
or 
EORTC 
Moderate intensity on EORTC - - - - Top 3 
highest 
mean 
score 
Symptoms 
reported 
by more 
than half 
of the 
patients    
- - 
 
Abbreviations: BPI, Brief Pain Inventory; EORCT QLQ-C30, European Organization for Research and Treatment of Cancer core module; EORCT QLQ-PAN26, European Organization for Research and 
Treatment of Cancer pancreatic cancer module; EQ-5D, European Quality of Life-5 Dimensions; ESAS, Edmonton Symptom Assessment Scale; FACT-G, Functional Assessment of Cancer Therapy 
general module; FACT-HEP, Functional Assessment of Cancer Therapy hepatobiliary module; MDASI, M.D. Anderson Symptom Inventory. 
a Shading cells represent relatively problematic symptoms  
b Digestive symptoms includes nausea and vomiting, flatulence, altered bowel movement and indigestion 
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CHAPTER THREE 
This chapter included data on the symptom experience of patients with APC and 
their caregivers as told to their healthcare providers (dissertation aim 2). This sub-study 
aids in understanding the complexities of the symptom experience of APC patients and 
caregivers and how they expressed their concerns and feelings.  
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Symptom Experiences in Patients with Advanced Pancreatic Cancer as Reported 
During Healthcare Encounters 
Pancreatic cancer is a prevalent and deadly form of cancer that is associated with a 
variety of severe and troubling symptoms. In 2016, an estimated 47,780 persons died 
from pancreatic cancer in the United States, making it the fourth leading cause of cancer 
deaths among adults.3-1 In contrast to the decreasing mortality rates for most other types 
of cancer, the death rate of pancreatic cancer has increased gradually over the past 
decade, and scientists predict it will be the second leading cause of cancer deaths by 
2030. 3-2 Due to the lack of effective prevention, early detection, and treatment 
interventions for pancreatic cancer, 3-3 less than 20% of patients are diagnosed at 
localized stage when they may be eligible for potential curative surgery, and the overall 
five-year survival rate for patients with advanced pancreatic cancer (APC) is about 1- 
3%.3-1  
Patients with APC often experience multiple distressing symptoms. Symptoms are 
perceived indicators of change in normal functioning as experienced by patients. 3-4 An 
integrative review of 16 studies published between 2005 and 2015 revealed that patients 
with APC experience a variety of symptoms including pain, fatigue/lack of energy, loss 
of appetite, dry mouth, taste change, digestive problems, respiratory problems, and poor 
sleep, with fatigue, loss of appetite, and pain being the top three severe symptoms 
reported. 3-5 Psychological symptoms included impairment in a sense of well-being, 
depression, and anxiety.  Some studies reveal that patients with APC have higher rates of 
psychological distress than patients with other types of cancer. 3-6-3-8  
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Patients with APC often experience a rapid transition from a healthy status to the 
terminal stage of their illness, which is a stage which is often marked by significant 
symptom burden. Optimal symptom management is particularly critical at the end of life 
as symptom experiences are closely linked to functional status, health related quality of 
life, good death, and decision making. 3-4, 3-9-3-11 Despite that effective symptom 
management is a primary healthcare goal for patients with APC, physical and 
psychological symptoms are often unrecognized or poorly managed by healthcare 
providers. 3-12-3-14 For example, one study revealed that patients with pancreatic cancer 
and their caregivers received little information regarding eating and digestive problems 
during their clinical visits, prompting them to seek information on their own. Moreover, 
these uncontrolled symptoms contributed to unresolved grief in bereaved caregivers. 3-13 
Improving symptom recognition and management for patients with APC calls for a 
better understanding of how patients experience their symptoms. While studies have 
identified physical and psychological symptoms that are common in this population, little 
is known about the symptom experiences of patients with APC from the patients’ 
perspectives and the perspectives of those who care for them. One source of information 
that can shed light on symptom experiences among patients with APC are the 
descriptions of symptoms offered by patients and their caregivers in the context of 
naturally occurring office visits with healthcare providers. The purpose of this study is 
therefore to examine recorded healthcare encounters between patients with APC, their 
caregivers, and healthcare providers to better understand the symptom experiences of 
patients with APC as told to their healthcare providers.  The study is based on the 
assumption that while not all aspects of patients’ symptom experiences would be revealed 
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to healthcare providers, patients and caregivers are likely to reveal information regarding 
symptoms that are alarming, bothersome, or distressing. Understanding what is salient in 
the symptom experiences of patients with APC can provide a foundation for the 
development of strategies by which healthcare providers can facilitate symptom 
discussions and manage symptoms that matter most to patients and their caregivers.   
Method 
A qualitative descriptive (QD) approach was used for this study.  QD studies 
provide a fundamental and low-interpretive description of the phenomenon of interest 
rather than a highly interpretive rendering of the data. 3-15, 3-16 This approach is widely 
used in health research when a pragmatic description of patient experiences is needed to 
address important practice issues. 3-16-3-18 Because we sought a straightforward description 
of how patients with APC experience symptoms, a QD approach was determined to be 
the most applicable method.  
Sampling  
The data for this study were drawn from transcripts of dialogue that occurred 
among patients with APC, their caregivers, and their healthcare providers during regular 
office visits. These encounters had been recorded for a large randomized controlled trial 
called the Values and Options in Cancer Care (VOICE, National Cancer Institute, 
R01CA140419, Clinical Trials Identifier: NCT01485627). The goal of the VOICE study 
was to test interventions designed to facilitate communication and decision making 
during healthcare encounters. Patients with stage three or four solid tumor cancers, their 
caregivers, and their oncologists were recruited from multiple oncology practices and 
cancer centers in the Rochester/Buffalo, NY and Sacramento, CA regions (2013—2015). 
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A total of 383 patients and 276 caregivers participated in the VOICE study, which is 
described in detail elsewhere. 3-19  
One office visit of the participating patients and, when available, their caregivers 
was recorded before the intervention and one was recorded following the intervention.  
On the day of the visits to be recorded, the research assistant met the participants in the 
waiting room, accompanied them to the clinic room, obtained verbal permission to record 
the visits, and activated two audio recorders before leaving the room. The research 
assistant collected the recordings after the visits and sent them to a professional medical 
transcription service. Because the aim of the current study was to explore how patients 
with APC experience symptoms, we chose to use only transcripts of pre-intervention 
visits so we could examine the most naturally occurring symptom discussions.  Thirty-
seven transcripts of pre-intervention visits were available for patients with APC. 
Data Analysis 
Standard content analysis was used to analyze the data. 3-20 The data were analyzed 
by three nurse researchers with expertise in oncology nursing and qualitative methods. 
The NVivo qualitative data analysis software (version 10; QSR International Pty Ltd, 
2012) and Microsoft Word (version 2609; Microsoft Office 365 ProPlus, 2016) were 
used to aid the analysis.  
The analysis was completed in six steps: (1) All members of the analysis team read 
through the transcripts to become familiar with the overall nature of all of the encounters; 
(2) The first author wrote a brief case description of each encounter; (3) The first author 
extracted and highlighted any text units [e.g., words, phrase, sentences] in which a patient 
or caregiver discussed the patient’s symptoms and labeled each with a  code, which is a 
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short phrase that captures the meaning of the text; (4) The second and third authors 
reviewed the case descriptions and verified the accuracy of the codes; (5) The first author 
constructed a descriptive table to organize, condense, and display the codes into 
categories. 3-21 The table was examined and discussed by the team in regularly scheduled 
meetings; and (6) The first author wrote a narrative description of the categories and how 
each category relate to the study aims.  
Results 
The results are based on the verbatim transcripts of 37 healthcare encounters 
between patients with APC, their caregivers, and their healthcare providers. Twenty-two 
of the encounters included the patient, a caregiver, and an oncologist; seven included the 
patient, a caregiver, an oncologist, and a nurse; five included the patient and an 
oncologist; two included the patient, a caregiver, a nurse, and two oncologists; and one 
included the patient, an oncologist, and a nurse (table 3-1). The encounters generally 
lasted between 5 and 54 minutes. 
As the focus of this analysis was on the patients’ symptoms as described by the 
patients and their caregivers, the sample includes 71 persons - the 37 patients and 34 
caregivers present during the encounters.  The mean age of the patients was 66, ranging 
from 44 to 92.  Twenty-one patients were females and 16 patients were males. Thirty-
three of the patients were receiving chemotherapy at the time of the encounter. One 
patient was receiving supportive care, and one was receiving hormone therapy. The type 
of treatment that two of the patients were receiving was unclear. Among the 34 
caregivers, 21 were spouses, 6 were children, 3 were siblings, 3 were friends, and 1 was 
the mother of the patient (table 3-2).  In this paper, we use the term participants when we 
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are referring to the patients and the caregivers together, whereas we use the terms patients 
and caregivers when we are referring to each group separately.  
During the encounters, the participants discussed a variety of symptoms that ranged 
from mild to severe or life-changing. At times, the participants initiated the symptom 
discussion on their own or in response to general provider questions (e.g., How are you 
feeling?), and at times the symptom discussion was in response to specific questions 
asked by the provider (e.g., No problem with eating?). When discussing the patients’ 
symptoms, the participants addressed three main topics: how the patients experienced 
their symptoms, the effect of the symptoms on their everyday lives, and the strategies the 
patients and the caregivers used to manage the patients’ symptoms. During the 
encounters, the participants identified 10 major types of symptoms: pain, fatigue, 
abnormal bowel movements, decreased appetite, nausea and vomiting, sleeping 
problems, neurological problems, skin problems, taste changes, and psychological 
distress.  How the participants described each of these 10 types of symptoms in regards to 
the three main topics are described below, with verbatim quotes included as examples.  
Pain 
In 33 of the encounters, the participants discussed the symptom of pain. While some 
patients indicated that they had had pain but that it had improved or was mild, some 
participants pointed out that the patients experienced on-going pain with the intensity 
varied greatly. A 57-year-old woman said, “And I mean like to the point where it would 
wake me out of a dead sleep I was in so much pain.” Some patients indicated that they 
experienced constant pain whereas others said that their pain was intermittent. A few 
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participants were asked to rate the level of patients’ current pain using a 10-point scale; 
these participants rated the patients’ pain between 3 and 6.  
Patients reported several different pain locations, although most often the pain was 
in the abdominal area. Some pointed out that their pain was located in upper-right 
abdomen or the “liver” area, whereas others said that the location of their pain was vague 
or that it “hops around.” Some said they had a “stomach ache,” and others described their 
abdominal pain as tender, cramping, sore, sharp, or piercing. The patients also described 
pain in other areas of their body. Some participants mentioned the patients’ had chronic 
back pain, and some patients discussed bone and joint pain in their hips and knees. One 
patient said that he had an “achy” pain in his joints. A few participants mentioned the 
patients’ muscle pain, injection-related pain, and chest pain.  
Many participants attributed patients’ pain to the growing of the pancreatic cancer. 
Other participants suggested other factors, such as injections, blood production, 
depression, overeating, a hernia, reflux, an ulcer, radiation, and even the weather, 
contributed to the patients’ pain. Some patients attributed their joint pain to 
chemotherapy as they experienced the pain following a treatment.  
Many participants shared how the patients’ pain was affecting their lives. Some 
patients stated that they could still perform daily activities despite the pain, while others 
said it interfered with normal activities. A 47-year-old woman with pain around her waist 
was limited in what she could wear. She said, “I mean a lot of it is I can’t wear anything 
with. . . anything on the waist.” Some patients revealed their pain interfered with their 
sleeping. Both the patients and caregivers indicated that the pain was distressing. Several 
participants revealed, however, that they also worried about the side-effects of pain 
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medications. A 74-year-old man said, “But then I was afraid to take any more of the 
Oxycodone for fear of getting nauseated again.”  
The participants discussed a number of strategies they used to manage pain. Most 
talked about using pain medications, including opioids, nonsteroidal anti-inflammatory 
drugs, acetaminophen, or drug combinations. Some patients reported that they took long-
acting pain medications around the clock plus short-acting medications for breakthrough 
pain. Other patients stated that they took pain medications only when they experienced 
pain or before special events. Some patients said that they cut back on pain medicines due 
to constipation or dislike of pain medicines generally. A 56-year-old woman said, “I 
don’t like pain medicine so I really. . . you know, I try not to take them unless…I need 
it.” Some patients mentioned that the chemotherapy was effective in alleviating pain 
while others discussed adjusting their chemotherapy schedule or stopping chemotherapy 
due to worsening pain. A few participants talked about the patients’ celiac plexus block 
and using strategies to improve patient comfort, such as applying ice or wearing loose 
fitting clothing.  
Fatigue 
In 29 of the encounters, the participants discussed the symptom of fatigue. While 
some stated that the patient’s fatigue was improved, tolerable, or fluctuating, many stated 
the patients endured severe or constant fatigue. The participants described fatigue in 
different ways; they stated the patients were fatigued, tired, had low energy, slept a lot, 
and had difficulty carrying out daily activities. One woman said that her husband “just 
can’t get himself out of the bed.” A few patients reported that they felt weak, “down,” or 
slow. Some participants were asked by providers to rate the level of the patients’ fatigue 
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using a 100-point scale with higher score indicating more fatigue; the score ranged 
between 60 and 70. On the other hand, some participants used a 100-point scale to rate 
the level of patient’s activity level with higher score indicating more active; the score 
ranged between 70 to 90.  
Many participants attributed the patients’ fatigue to chemotherapy as the fatigue 
typically began within hours to three days of receiving chemotherapy and improved on 
the fourth or fifth day. A 81-year-old man said, “You know, after the chemo a couple of 
days I’m not. . . that, I just feel sluggish.” However, a few participants indicated that the 
patients’ fatigue continued more than a week after chemotherapy and even got worse. A 
few participants suggested that other factors, such as aging, infections, diarrhea, dry 
mouth, or acid reflux, may contribute to the patients’ fatigue.  
Many participants shared how the patients’ fatigue was affecting their lives, 
especially the ability to do daily activities. Participants pointed out that the patients either 
slept all day or took naps during the day and this interfered with their night-time sleeping 
and their eating schedule. Some patients discussed how their ability to work or exercise 
was impaired. A 66-year-old man said, “If I’m out working on the car in the garage and I 
work for a few hours I get really tired.  I’ll come in and that’s it.  The next day I feel like 
I’m wiped out.” A few participants stated that the patient’s fatigue interrupted their travel 
plans.  
Both the patients and caregivers indicated the fatigue were distressing. Some 
patients revealed that they were “hit” by fatigue. One 56-year-old woman said, “Just the 
worst thing is the fatigue.” Some caregivers disclosed that they were quite bothered about 
the patients’ fatigue. One caregiver, whose husband was so tired that he slept nearly all 
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day, complained that their life had changed dramatically. She said, “He’s not even with 
me… it’s like cancer is married to him now and I’m not.  So, the cancer is with him all 
the time and I’m [along] in the room.” In some instances, the patients and caregivers 
described the fatigue differently. For example, when one patient stated that his fatigue 
was not too bad, his wife interrupted him saying that she did not like him being so 
fatigued. Another patient decided to discontinue chemotherapy due to fatigue even 
though she knew that her family disagreed with this choice.  
The participants identified a number of strategies they used to manage fatigue. 
Some participants discussed adjusting the patients’ chemotherapy schedule, and a few 
patients questioned the necessity of continuing chemotherapy as they became weaker. 
Some participants mentioned that the patients slept more to restore energy and walked or 
exercised to relieve their fatigue. Patients discussed using medications to increase their 
energy, trying to eat “healthy” to combat the fatigue, or setting up eating plan if they 
were too tired to eat. A few patients discussed being admitting to the hospital to manage 
the severe fatigue or receiving a blood transfusion to manage fatigue or fatigue-related 
problems.  
Abnormal Bowel Movements 
In 26 of the encounters, the participants discussed the symptoms of diarrhea and/or 
constipation. While some participants described the patients’ bowel movement as natural, 
good, regular, or solid, other patients complained of diarrhea, constipation, or both.  
Some patients described diarrhea or “loose stools” that ranged from mild to severe, and 
some indicated that the intensity and frequency of diarrhea fluctuated. A few patients 
reported that they experienced diarrhea continually through the day and night and needed 
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to spend much time in the bathroom. One patient referred to her diarrhea as “morning 
sickness” because she typically experienced it in the morning.  Another patient described 
abdominal pain that occurred with the diarrhea. Many participants attributed the diarrhea 
to chemotherapy, and one caregiver suggested it was due to an infection.  Fewer patients 
discussed constipation, but those that did described it as aversive or “terrible” and often 
attributed it to their pain medicines. One patient described changes in the appearance of 
stool and described it as having an “ugly greenish stool which does not look good.”  In 
some instances, there was inconsistency in how the patients and caregivers described 
changes in bowel movements or how bowel movements were described at different 
points in the encounter. For example, one patient said that he had no problem with bowel 
movements, whereas his caregiver said he had had several episodes of irritating diarrhea. 
Later in the encounter, the patient revealed that he had in fact had frequent diarrhea 
during the past month. In another instance, in the beginning of the encounter the 
participants described the patient’s bowel movements as regular but later indicated that 
he had experienced both diarrhea and constipation.  
Many participants shared how diarrhea and constipation were affecting the 
patients’ lives. Some patients revealed that the diarrhea interrupted their sleep and daily 
activities. For example, one patient mentioned that the diarrhea kept her close to home 
and prohibited her from enjoying outdoor activities. Another 74-year-old male said, “I 
had the buffet and all that and I couldn’t even eat the buffet because every couple of 
minutes I had to go to the bathroom.” One caregiver said that her husband’s diarrhea 
contributed to his fatigue. Many participants expressed that diarrhea and constipation 
caused psychological distress, fear, and irritation. One patient stated that he could “live 
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with” his diarrhea, and another said that having frequent bowel movements was better 
than being constipated.  
Participants discussed several strategies that they used to manage the patients’ 
diarrhea and constipation. Most talked about the patients taking anti-diarrhea drugs or 
stool softeners that had varying degrees of effectiveness. A few participants requested 
advice from the healthcare provider about how to manage these symptoms. One patient 
mentioned that he could not manage his constipation by drinking fluids, and another 
patient requested longer rest periods between chemotherapies due to his diarrhea. One 
patient asked the oncologist to prescribe medicine to prevent diarrhea, and another patient 
described how she took fewer iron supplements that cause constipation.  
Appetite Change 
In 23 of the encounters, the participants discussed the symptom of appetite 
change. While some stated that the patient’s appetite was good or had improved, others 
described the patient’s appetite as poor or decreased. Some participants indicated that the 
patients ate nearly nothing. For example, one caregiver stated that her husband “eats like 
a bird.” A few participants indicated that the patients were not able to eat as much as they 
once did. An 80-year-old woman said, “Like I just had lunch at the Char Broil and I ate 
half of what I used to eat.” A few caregivers pointed out that the patients’ appetite 
problems were on-going. Some patients attributed their appetite change to nausea and 
vomiting, and one caregiver said that her husband’s appetite change occurred after 
chemotherapy.  
Many participants shared how the patients’ appetite change was affecting their 
lives, especially their eating and their weight. One patient questioned if his appetite 
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change was related to his cancer spreading. Both the patients and caregivers indicated the 
patients’ appetite changes were distressing. Several caregivers, for example, revealed that 
they became frustrated when the patients would not eat. Conversely, one caregiver 
indicated that she felt “proud” when her husband ate well.  
The participants discussed a number of strategies they used to manage appetite 
changes. Some described “force-eating,” that is, the patients tried to eat regardless of 
their appetite. Others mentioned strategies such as taking pancreatic enzymes, using 
steroids, identifying the patient’s favorite food, eating small and frequent meals, and 
setting eating goals. Several caregivers said that they tried to identify foods that patient 
would be interested in eating. For instance, one caregiver mentioned how she purchased 
all of the cookbooks recommended by the dietician in order to prepare food that would 
improve her husband’s appetite. One patient pointed out that she closely monitored her 
weight, and one caregiver shared how she consulted with a nutritionist about her 
husband’s eating problems.  
Nausea and Vomiting 
In 20 of the encounters, the participants discussed the symptoms of nausea and/or 
vomiting with their healthcare providers. They described nausea that ranged from none to 
“a small touch” to severe. In some cases, the nausea was accompanied by vomiting, and 
some participants reported when and how long the patients vomited. For example, one 
caregiver indicated that he considered his wife’s nausea to be severe because it lasted 
over a week. Many participants revealed that the nausea and vomiting occurred during or 
the couple of days after chemotherapy. Several mentioned that these symptoms arose 
after the patients ate. One patient mentioned experiencing relief after vomiting because 
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the food was just “sitting there.”  Other participants attributed the nausea and vomiting to 
other causes. One indicated that the nausea was triggered by pain medicine, whereas 
another indicated that the symptoms were due to an infection. One patient mentioned that 
she became nauseous when brushing her teeth. 
Many participants shared how nausea and vomiting were affecting the patients’ 
lives. For some patients, these symptoms impacted their daily lives profoundly. Many 
patients revealed that the nausea and vomiting brought uncertainty, worry, and fear. They 
talked about being worried about throwing up important medications and being afraid of 
taking pain medications that could trigger nausea. One patient stressed that the severe 
vomiting “set back [his] life” and questioned the value of taking so many medicines when 
he continuously experienced severe vomiting as a result.  Several mentioned that nausea 
and vomiting affected their eating, especially of foods that triggered these symptoms. 
Some described how nausea and vomiting impeded their daily activities such as working 
or doing housework. One 56-year-old woman mentioned that the medication she was 
given for nausea affected her life as its sedation effects isolated her and prevented her 
from doing daily activities. She said, “It [Compazine] puts me into a very different type 
of state like where I’m almost not aware of someone maybe coming in the front door.” 
Her caregiver stated that taking Compazine made the patient “sleep like a zombie.”  
Participants discussed several strategies that they used to manage the patients’ 
nausea and vomiting. Most talked about the anti-nausea drugs taken by the patients but 
indicated these drugs were not always effective and were sedating. A few participants 
mentioned the strategy of “forced-eating,” which was trying hard to eat and holding 
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things down regardless of the nausea. One patient requested to postpone chemotherapy 
because of severe vomiting. 
Sleep Problems 
In 17 of the encounters, the participants discussed problems with sleep. Many 
revealed that the patients had poor sleep quality, including difficulties falling asleep, 
waking up during the night, and confusing day and night.  A 62-year-old man said, “I’d 
wake up at 1 in the morning and I am awake.  So, I get up, sit.  I didn’t want to turn the 
[light] on to get stimulated so I just sit for an hour, lay back down, wake up again at 4.  
So it was a terrible pattern.” Some patients indicated that these sleep problems lasted for 
some time. Many participants attributed the patients’ sleeping problems to other 
symptoms such as pain, diarrhea, and psychological distress. Some participants indicated 
that due to fatigue the patients slept nearly all day and thus could not sleep at night. One 
patient, for example, said that he slept poorly at night because he took frequent naps 
during the day. One patient suggested that aging affected his sleep.  
Many participants shared how sleep problems were affecting the patients’ lives. 
One patient reported that he could not drive because he was using sleeping pills. Other 
participants revealed that their sleeping problems or the need for sleeping medications 
caused psychological distress. A 73-year-old man said, “I hate to use it [drug] because I 
can’t hardly wake up the next day.” A few caregivers articulated their frustration and 
worry about the patients sleeping too much or using sleeping pills.  
Participants discussed some strategies that they used to manage the patients’ 
sleeping problems. Most talked about the sleeping pills the patients used. Some 
participants reported that sleeping medications helped the patients sleep well at night, 
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whereas others reported sleeping medications were not effective. Some participants 
reported that using effective strategies to manage related symptoms, including pain and 
diarrhea, would help the patients’ sleep. A few participants described trying to keep 
themselves awake during the day so they could sleep better at night.  
Neurological Problems 
In 15 of the encounters, the participants discussed neurological symptoms. Some 
participants referred to these symptoms as “neuropathy.” Many revealed that the patients 
experienced abnormal sensations, including tingling and/or numbness in fingers and toes, 
sensitivity to cold, insensitivity to pressure, and sensitivity in their mouths or hands. For 
instance, a 60-year-old woman described that she had “a little bit of tingling in my 
fingers.” She said, “It’s just like when I grab something out of the freezer or refrigerator.” 
Most participants indicated that these abnormal sensations were mild or intermittent and 
often resolved within hours to a week after chemotherapy. Some patients reported other 
types of neurological symptoms such as balance issues, dizziness, and blurred vision.  
Many participants shared how neurological symptoms were affecting the patients’ 
lives. Some patients described needing the help of others because they had difficulty 
writing and holding things. A couple of participants reported that eating and drinking 
were problematic.  For example, one patient stated that because he could not tolerate 
drinking cold liquids, he could not take dietary supplements although he had a poor 
appetite and significant weight loss. Some patients indicated that their neurological 
problems had caused minimum disruption, and one patient said that he was learning to 
live with the numbness.   
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Participants discussed some strategies that they used to manage the patients’ 
neurological problems. Some patients talked about taking vitamins or supplements to 
strengthen neurological function or being mindful about their balance problems to 
prevent falling. A 67 year-old man said, “I have to watch my balance a little bit.” A few 
patients talked about getting assistance from others to carry out tasks, eating food at room 
temperature, and wearing glasses for vision changes.   
Skin Problems 
In 13 of the encounters, the participants discussed skin problems, including 
problems with their hair and nails. They discussed skin rashes, dry skin, and itching. 
Many revealed that patients experienced severe rashes on their hands, arms, or faces 
during or after chemotherapy. A few patients mentioned their skin rash or “red sole” had 
slowly improved. Several participants said that patients had dry or “rough” skin, 
especially on their hands. Some patients reported that they experienced severe itching all 
over their body. One patient pointed out that the itching typically occurred at bedtime. A 
few patients described other uncomfortable skin sensations. One patient stated that she 
felt “stingy,” and another complained that her knuckles were uncomfortable. Although 
most participants attributed skin problems to chemotherapy, a few caregivers suggested it 
was due to other causes such as exposure to sun or poison ivy. One patient pointed out 
that his skin rash was caused by scratching.  
Many participants revealed that the patients’ hair and/ or nails were affected.  
Some patients described the loss of some or part of their hair or toe nails, and others 
described the fragility or abnormal appearance of their hair and nails. For example, one 
  
70 
 
patient said that she had “shabby” nails and revealed that her hair was “coming out in 
clumps.”  
Many participants shared how skin problems were affecting the patients’ lives.  
Some patients complained that itching interfered with their sleep. While one patient 
stated that he kept scratching during sleep, his wife pointed out that she believed that the 
pruritus drug facilitated his sleep. Several participants said they felt shocked, bothered, or 
irritated by their rash or itching.  A 65-year-old woman mentioned, “My only thing is I 
would want to know what to do about these little things [rash] that become irritants.” A 
few patients stated that they were distressed about hair loss. A 81-year-old woman said, 
“I want a family picture before I lose it all.” In some cases, patients and caregivers 
differed in their reports of the severity of the skin problems, especially hair loss. For 
example, patients reported feeling depressed about her hair loss but were reluctant to 
wear a wig, whereas their caregivers denied the depression and encouraged them to wear 
a wig.  
Participants discussed several strategies they used to manage the patients’ skin 
problems. Many mentioned consulting with dermatologists, using medication for their 
rashes, and keeping their skin moist. Some patients said that they just scratched their skin 
when itchy. A few patients talked about avoiding sun exposure or protecting fragile nails.  
Several indicated that they got a wig when they lost their hair. 
Psychological Distress 
In 12 of the encounters, the participants discussed various types of psychological 
distress. Some participants indicated that the patients experienced anxiety and fear about 
their own health and the welfare of their families due to the seriousness of the illness. 
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One 42-year-old woman said,” I just [worry about] my kids. My little guy. Because he 
has Down’s Syndrome. I'm worried.  That he’ll forget me.” Participants revealed that 
some patients also experienced sadness or depression. Some patients cried when 
expressing these feelings. For example, one patient tearfully revealed that she was not 
prepared to discuss the progression of her disease because she “felt so good” at the 
present time. In some instances, caregivers minimized the psychological distress 
mentioned by the patients. For example, when a 56-year-old woman said that she was 
“down” for the whole day because of anxiety, her husband said, “I don't think it was [the 
anxiety] …Just that because when she crashes, she’s out.” 
Many patients shared how their psychological distress was affecting their lives. 
Some patients indicated that their physical symptoms were worsened by their 
psychological distress. A 60-year-old woman attributed her stomachache to her anxiety.  
She asked, “I think maybe it’s [due to] nervousness, maybe, do you think?” Some 
patients indicated that their ability to process information and concentrate was affected by 
their psychological distress.  An 81-year-old woman, when told that her chemotherapy 
was ineffective, said, “Well, I can’t think of anything… I haven’t heard half what you 
said.”   
The participants discussed a number of strategies they used to manage their 
psychological distress. Most mentioned taking medications to manage their anxiety and 
depression. Some indicated that their psychological distress improved as a result of using 
drugs that were not originally prescribed for psychological symptoms. When discussing a 
chemotherapy regimen containing a steroid, a 56-year-old woman said, “But I found. . . 
no, it wasn’t bad.  I mean I kind of. . . it [steroid] gave me a sense of well-being.” Some 
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patients talked about consulting other physicians about their psychological distress, and a 
few stated that they had learned to accept it. One caregiver suggested to her mother that 
she write herself notes when her psychological distress got in her way of thinking clearly. 
Taste Change 
In seven of the encounters, the participants discussed the symptom of taste change. 
Some patients described how they had lost their sense of taste. A 56-year-old woman 
said, “My taste buds are shut.” Some patients said that they got a “bad taste” in their 
mouth during or after eating. One patient pointed out that he got bitter taste after eating, 
food did not taste like food, and he experienced the texture of food differently. Some 
patients indicated that taste change started at the beginning of the chemotherapy, 
typically lasted weeks after chemotherapy, and, in some cases, then returned to normal.  
Many participants shared how taste change was affecting the patients’ lives.  Some 
participants considered taste change as a main barrier of eating despite that the patients 
had good appetite. One 67-year-old man described constant pressure from his family to 
eat, which he found to be frustrating.   
Some participants discussed several strategies that they used to manage the patients’ 
taste change. Some caregivers suggested that patients eat anyway, and some patients said 
that they tried to find food that was still enjoyable. One caregiver described how her 
added dietary supplements, and one patient disclosed that he had no idea how to deal with 
taste change.  
Infrequently Mentioned Symptoms 
  There were some symptoms that were mentioned only in passing by a small 
number of participants. These symptoms included abdominal bloating, generalized 
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discomfort, mouth sore, dry mouth, swallowing difficulties, indigestion, breathing 
problems, and hot flashes.  
Discussion 
The findings of this study describe how patients with APC experience their 
symptoms based on how they and their caregivers describe the symptoms to their 
healthcare providers during scheduled office visits. The participants discussed a variety 
of symptoms, including pain, fatigue, abnormal bowel movements, decreased appetite, 
nausea and vomiting, sleeping problems, neurological problems, skin problems, 
psychological distress, and taste changes.  Many participants reported multiple symptoms 
including some that were severe or highly distressing.  Although the participants 
attributed the patients’ symptoms to a range of factors, the most common were the 
worsening of the cancer and the side effects of treatments, especially chemotherapy.  
Many patients revealed that their symptoms affected their daily lives profoundly by 
interfering with their eating and sleeping, working, traveling, and self-care. They also 
reported that the symptoms could cause psychological distress and affect their cognitive 
functioning.  In addition to taking medication to treat some of the symptoms, the 
participants indicated that the patients used a variety of strategies to manage their 
symptoms such as changing their eating habits to lessen their nausea, finding foods that 
appealed to them despite taste changes, applying ice to lessen pain, and exercising to 
combat fatigue. In some cases, they consulted with other healthcare professionals, such as 
nutritionists or mental health providers, about their symptoms. Some patients requested a 
modification or termination of chemotherapy because their symptoms had become 
unbearable.  
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These findings are consistent with quantitative evidence related to the variety and 
severity of symptoms experienced by patients with APC.  For example, the symptom 
groups that emerged in our study overlapped considerably with the symptom groups 
revealed in the integrative review mentioned previously. 3-5 In fact, the symptoms 
discussed most frequently by our participants – pain, fatigue, and abnormal bowel 
movements – were similar to the top three severe symptoms revealed in the review – 
fatigue, loss of appetite, and pain.  Moreover, our findings related to the attributions 
patients make about the etiology of their symptoms are consistent with findings from 
prior research.  Just as we found that patients associated changes in their symptoms with 
the worsening of their illness, other researchers have reported that patients and caregivers 
view uncontrolled cancer pain as a sign of disease progression. 3-22, 3-23  
Our findings also confirm and extend the findings of other studies that address 
symptoms in cancer patients generally. Fatigue, for example, is reported to be a 
distressing symptom in the general cancer population. 3-24, 3-25 Our finding of the diverse 
description of fatigue (e.g., tired, low energy, can’t get out of bed) is similar to a 
synthesis of qualitative research revealed that patients with a variety of types of cancer 
also describe their fatigue with a wide array of words and phrases (e.g., tired, weak, 
exhausted). 3-26 Similarly, just as the synthesis revealed that the physical and 
psychological impact of cancer-related fatigue is considerable, 3-26 our findings indicate 
that fatigue affects the lives of patients with APC in profound ways.  
The recommendations stemming from prior studies that more attention be given to 
appetite and taste changes, which have been found to be problematic for both patients and 
caregivers, 3-27, 3-28 are consistent with our findings.  Our findings also support other 
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studies that have revealed that constipation, nausea, and vomiting interfere with cancer 
patients’ lives in significant ways, affect their adherence to medication, and cause 
psychological distress. 3-29, 3-30 Although some of our participants were quite troubled by 
diarrhea as well, few studies have addressed the life disruptions caused by diarrhea from 
the perspective of the cancer patients. While many studies with cancer populations focus 
on peripheral neuropathy, 3-31 our participants discussed a variety of types of neurological 
symptoms as well as skin problems that may be overlooked in the literature. 3-5 
Psychological distress, such as discussed by our participants, has been well documented, 
3-6 although some studies focus more on physical rather than psychological symptoms. 3-5   
Other researchers have also reported that patients and caregivers often perceive the 
patients’ symptoms differently. 3-32, 3-33 Whereas some studies indicate that caregivers 
tend to overestimate cancer patients’ symptoms, 3-32, 3-34 the caregivers in our study 
contradicted the patients’ descriptions of symptoms in a variety of ways, including 
challenging how the patients described the symptoms, pointing out symptoms to 
providers that the patients failed to mention, or suggesting the symptoms were not as bad, 
or conversely worse, than described by the patients.  
Limitations 
Our findings should be understood in the context of the study limitations. The major 
limitation is that we used a data set that had been established for another study.  Although 
there was advantage to using recorded healthcare encounters because the symptom 
discussions occurred naturally rather than in the context of a retrospective research 
interview, we recognize that these recordings do not offer complete descriptions of 
patient symptom experiences. For example, the participants may have been reluctant to 
  
76 
 
disclose psychological symptoms that could be stigmatizing, such as depression or 
suicidality, or may have neglected to mention minor, but nonetheless bothersome, 
symptoms that they assumed were not important enough to bring up. We also recognize 
that the questions providers ask or the interest they show in certain symptoms can 
influence the nature of symptom discussions during the encounters, but an analysis of the 
effects of provider behaviors on symptom discussions by patients and caregivers was 
beyond the scope of this report.  
Future Research 
While this study provides fundamental information on the symptom experiences of 
patients with APC, more studies are needed to obtain a comprehensive description of 
these symptom experiences as they unfold throughout the course of the patients’ illness. 
Longitudinal studies in which patients and their caregivers journal symptom experiences 
over time, including how these symptoms are affecting their day-to-day lives, would 
overcome the primary limitations of our study. Such methods could obtain information 
on symptom experiences that might not be adequately addressed in healthcare encounters 
or in retrospective research interviews. Future studies could also examine how 
communication patterns between patients, caregivers, and providers influence how 
symptoms are addressed in healthcare encounters.  For example, such studies could 
explore how healthcare providers and caregivers encourage or discourage the discussion 
of some symptoms by patients with APC.   
Clinical Implications 
The findings of this study suggest that healthcare providers should be attuned to 
the wide variety of ways in which patients with APC experience symptoms, how these 
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symptoms affect their day-to-day lives, and how they and their caregivers attempt to 
manage their symptoms. Understanding symptom experiences from the perspectives of 
patients and caregivers will help providers appreciate what aspects of the symptoms 
experiences are most bothersome, what makes the symptoms become intolerable, and 
what assistance is desired in managing these symptoms.  Soliciting patient and caregiver 
narratives about symptom experiences in addition to more structured assessments of the 
nature, severity, and course of the symptoms will allow providers to understand the role 
of symptoms in the context of the patients’ day-to-day lives.  This understanding will 
then inform the development of a comprehensive approach to symptom management.  
Conclusions 
To our knowledge, this is the first qualitative study to explore the overall symptom 
experience of patients with APC.  Patients and caregivers discussed a wide range of 
symptoms during healthcare encounters and revealed that these symptoms could affect 
their lives in substantial ways.  Our findings support prior research that identified 
symptoms most often experienced by patients with APC but extend these findings by 
providing descriptions of how these symptoms are experienced, how they affect the daily 
lives of patients and caregivers, and how patients and caregivers manage these symptoms. 
We argue that obtaining symptom narratives from patients and caregivers can reveal what 
concerns are most salient to them and that this information can inform their care.  
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Table 3-1.  
Composition of the Participants in Healthcare Encounters (n=37) 
 
 n % 
Patient, a caregiver, and an oncologist  22 59.46 
Patient, a caregiver, an oncologist, and a nurse  7 18.92 
Patient and an oncologist  5 13.51 
Patient, a caregiver, two oncologists, and a nurse 2 5.41 
Patient, an oncologist, and a nurse 1 2.70 
 
 
 
Table 3-2.  
Demographic data of Patients and Composition of Caregivers  
 
 n  % or mean 
Patients 37 100 
Age  - 66 
Gender    
Female  21 56.76 
Male  16 43.24 
Treatment type   
Chemotherapy  33 89.19 
Hormone therapy  1 2.70 
Supportive care only  1 2.70 
Unclear  2 5.41 
Caregivers  34 100* 
Husband 8 23.53* 
Wife 13 38.24* 
Mother 1 2.94* 
Daughter 5 14.71* 
Son  1 2.94* 
Brother  1 2.94* 
Sister 2 5.88* 
Friends  3 8.82* 
Note. * Among all participated caregivers for advanced pancreatic cancer patients 
(n=34) 
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CHAPTER FOUR 
This chapter describes sub-study 3 which explored how patients with APC and 
their caregivers interact with healthcare providers in regards to symptoms and symptom 
management (dissertation aim 3).  
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Patterns of Interactions Among Patients with Advanced Pancreatic Cancer, Their 
Caregivers, and Healthcare Providers During Symptom Discussions 
Managing symptoms effectively is a primary goal for terminally ill patients, their 
caregivers, and healthcare providers. Patients with advanced pancreatic cancer (APC), 
who often have limited curative treatment options and can experience a rapid transition 
from healthy status to a terminal stage of their illness, have considerable physical and 
psychological symptom burden. 4-1 Evidence shows that symptom management is often 
problematic for this population, 4-2 and poorly managed symptoms can have a profoundly 
negative effect on the quality of life of patients with APC and their caregivers. 4-2-4-4  
Symptoms are often the major topic of conversations between cancer patients and 
providers. 4-5, 4-6 Effective symptom management is one of the critical outcomes of 
effective patient/caregiver and provider communication. 4-7-4-10 Research has shown that 
effective communication with providers can alleviate the psychological and physical 
symptom burden of patients in four ways: 1) encouraging expression, 2) evaluating the 
symptoms, their impacts, and the effectiveness of interventions, 3) providing support, and 
4) enhancing self-management and perceived control over the symptoms. 4-7, 4-11, 4-12  
Despite its importance, a dearth of studies has addressed how patients, caregivers, 
and providers discuss symptoms and symptom management during healthcare 
encounters.  A few studies, however, have shown that the quality of these symptom 
discussion might not be optimal. 4-13-4-15 For example, some research has indicated that 
cancer patients are often discouraged from expressing their feelings about their symptoms 
and their concerns about what the symptoms indicate. In one qualitative descriptive study 
that described interactions between providers and patients reporting cancer pain (n=84), 
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researchers found that clinicians asked five times more close-ended questions than open-
ended questions during symptom discussions and interrupted cancer patients in more than 
half of the symptom discussions. 4-16 Moreover, several studies have revealed that a 
significant number of cancer patients report that they have not discussed, or did not want 
to discuss, their significant symptoms with healthcare providers. 4-12, 4-17-4-19 Many cancer 
patients also report that they do not receive symptom management recommendations 
from healthcare providers. 4-12, 4-19 In a 2009 systematic review, Jacobsen and colleagues 
synthesized 37 studies with more than 6000 cancer patients that examined barriers to 
cancer pain management. They found that communication about pain was studied less 
than other factors, and that studies that did examine the quality of pain communication 
reported that it was often not satisfactory. More research is therefore warranted to 
understand patient/caregiver and provider communication regarding symptoms and 
symptom management.   
The purpose of this study was to develop a typology to describe patterns of 
interactions between patients with APC, their caregivers, and healthcare providers in 
regards to symptoms and symptom management. The findings can provide foundational 
information needed to develop strategies to improve symptom discussions in healthcare 
encounters for this population. 
Method 
A thematic analysis of audio-recorded interactions between patients with advanced 
cancer, their caregivers, and healthcare providers during naturally occurring office visits 
was conducted.  
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Thematic analysis as described by Braun and Clarke (2006) was the method used in this 
study.  Thematic analysis is widely used in health research to identify, analyze, and report 
patterns within data. 4-20 According to Braun and Clarke, a theme “captures something 
important about the data in relation to the research question, and represents some level of 
patterned response or meaning within the data set.” 4-20 Thematic analysis can be used 
flexibly as it allows researchers to determine themes that best answer their research 
questions.  
Thematic analysis offers researchers several options for research design. First, 
thematic analysis can be used as an inductive or deductive approach. Inductive analysis is 
a data-driven and “bottom-up” approach in which themes are derived from empirical 
data. Deductive analysis is a theory-driven and “top-down” approach in which data are 
analyzed as they relate to themes drawn from established frameworks. Second, themes 
can be derived at the semantic or latent level.  Semantic themes capture the explicit or 
surface level meanings of the data, whereas latent themes reflect the assumptions or 
concepts the underlie the data and give form to patterns of data. Our study was an 
inductive thematic analysis because we allowed the themes to emerge from the 
transcribed encounters rather than fitting the data into pre-determined themes drawn from 
a specific theoretical framework. Our themes were identified at the latent level as we did 
not just describe what the patients, caregivers, and providers said but instead interpreted 
the underlying meaning of the interactions.  
Sampling  
The Indiana University Human Subjects Office Institutional Review Board 
approved this study. De-identified transcripts of APC patients’ audio-recorded office 
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visits were selected from a large randomized controlled trial called the Values and 
Options in Cancer Care (VOICE, National Cancer Institute, R01CA140419, Clinical 
Trials Identifier: NCT01485627). The VOICE study recruited patients with stage three or 
four solid tumor cancers, their caregivers, and their oncologists from New York and 
California regions (2013—2015) to test an intervention designed to facilitate 
communication and decision making. Detailed recruiting process and study methods were 
described elsewhere. 4-21 Although one pre-intervention visit and one post-intervention 
visit were recorded in the VOICE study, we only included and analyzed 37 transcripts of 
APC patients’ pre-intervention visits to capture most naturally occurring interactions.  
Data analysis 
Three nurse researchers with expertise in oncology nursing and qualitative methods 
analyzed the data. The NVivo qualitative data analysis software (version 10; QSR 
International Pty Ltd, 2012), Microsoft Word, and Microsoft Excel (version 2609; 
Microsoft Office 365 ProPlus, 2016) were used to organize the data and facilitate the 
analysis. Following the guidelines suggested by Braun and Clarke (2006), the analysis 
was conducted in six phases.  The six phases were as follows: 
Phase 1: Familiarizing yourself with your data. All members of the analysis team 
read through the transcripts several times to become familiar with the overall nature of all 
encounters. 
Phase 2: Generating initial codes. The first author extracted all data related to 
interactions that were pertinent to symptoms or symptom management. Interactions in 
which providers, patients, and caregivers worked out routine details of care or treatment 
(e.g., prescribing medicines, scheduling appointments) or engaged in small talk were not 
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extracted. The first author then divided all dialogue into meaningful segments of text and 
coded each segment with a label that captures its essence.   
Phase 3. Searching for themes. Each team member individually compared and 
contrasted the codes and organized common codes into themes.  
Phase 4. Reviewing themes. The analysis team met on several occasions to review 
potential or “candidate” themes.  Each team member presented the themes that they 
arrived individually to the group, discussed the essence of the themes, and shared 
examples from the transcripts that exemplified the themes. Through consensus and 
discussion, the team agreed on eight themes. Upon further discussion, the team 
determined that each of the themes reflected unique interaction patterns between 
providers, patients, and caregivers.  
Phase 5. Defining and naming themes. The team met again to name each theme, 
or interaction pattern, to define the patterns, and to determine the core characteristics of 
each patterns.  Using this information, the first author then returned to the data and placed 
each interaction in one of the eight patterns. The other team members verified the 
placement of the interactions by reviewing the transcripts. 
Phase 6. Producing the report. The first author wrote a narrative report that 
described each pattern and provided exemplar that best reflected each pattern.  The other 
team members reviewed and verified the report.  
Results 
Based on the transcripts of 37 healthcare encounters, the team identified eight 
themes that they determined reflected eight unique types of interaction patterns among 
patients, caregivers, and healthcare providers. The eight interaction patterns were as 
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follows: collaborative interactions, explanatory interactions, agentic interactions, 
checklist interactions, cross-purpose interactions, empathic interactions, admonishing 
interactions, and diverging interactions. Most encounters included the patient, a 
caregiver, and an oncologist, and in some instances, a nurse.  The encounters included 
117 persons: 37 patients, 34 caregivers, 37 oncologists, and 9 nurses.  The encounters 
lasted between 5 to 54 minutes.  Most of the encounters included several of the 
interaction patterns.  In some encounters, one pattern dominated the encounter, whereas 
in others, several patterns stood out over the course of the encounter.  The interaction 
patterns, their defining characteristics, and exemplars of each are discussed below. 
Collaborative Interaction Pattern 
In 31 of the healthcare encounters, an interaction pattern occurred that we have 
labeled as collaborative interactions. Collaborative interactions are those in which the 
patients/ caregivers and providers worked together to figure out the nature of a symptom 
or a course of action. This interaction pattern typically had a “two-way” feeling and 
neither the patients and/or caregivers or providers dominated the conversations. During 
the conversations, the providers often acknowledged what patients or caregivers had said. 
In one interaction, for example, when the patient said he wanted to manage fatigue at 
home instead of staying at the hospital, his wife responded by saying, “Okay.  I hear you.  
We’ll do it.” In several cases, the providers asked for input from patients or caregivers or 
began the interaction with an open-ended question.  One provider began a collaborative 
interaction with the question, “How do you deal with exercise?” During the collaborative 
interactions, some patients expressed their trust in the providers and seemed to appreciate 
making decisions jointly.  
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An example of a collaborative interaction follows.  In this interaction, a 73-year-old 
man, his wife, and the oncologist discussed discontinuing chemotherapy.  Each 
contributed to this treatment decision:  
Oncologist:      But with the pain changing this much I am worried that the cancer  
might be growing, Mr. [Patient]. 
Patient: Well, that’s what I said to my wife, is I don't know this chemo’s  
working. 
Oncologist: Right. 
Patient: It just seems to be growing. 
Oncologist: Right. I. . . I think so, too.  You know, and I feel that - 
Patient: Can we. . . can we prove that through tests somehow? 
Oncologist: We can.  It’s not . . . doing scans at such short interval, you know, 
just a few weeks apart, sometimes the scans don’t catch up to 
what’s actually happening in the body which is why we have to 
wait, you know, six weeks or something.  But if you think that it 
will help you decide that let’s put this final chemo, you know, put 
to rest and know that it’s not working then we’ll do the scan.  I. . . I 
don't know if we need the scan, Mr. [Patient], because, you know, 
everyone at home and we here who know you see the change.  
Right?  You have never required a pain pill in clinic, right? 
Patient: Yeah. 
Oncologist: And so I think whether the scan shows growth that can be 
measured, you know, I don't know if that’s. . . we need that. I think 
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that I have enough evidence here for me to say that this chemo is 
not working. 
Patient: Oh, okay.  Unless. . .  
Oncologist: Yeah, I think so. 
Patient: I’ll go with the Lord. 
Oncologist: Yeah, because I just. . .  
Patient: I have a lot of good faith for the Lord and I carry him with me  
everywhere I go.  Along with my. . . along with my navy anchor. 
[Laughter]  
Oncologist: They go together, right? 
Patient: Yeah, why don’t we just stop it. 
Oncologist: Yeah, because if I felt that it was just the tiredness or if you were  
having some side effects we would come up with some way to get 
through.  But I think that, you know, and we’ll have blood work, 
we’ll have some tests there. 
Patient: Are you okay with that [to his wife]? 
Caregiver: Hmm? 
Patient: Are you okay with that? 
Caregiver: It’s your decision.  Your decision.  I would say he was more tired 
this week than before.  Honestly… 
Explanatory Interaction Pattern 
In 28 of the healthcare encounters, an interaction pattern occurred that we have 
labeled as explanatory interactions. Explanatory interactions are those in which the 
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providers gave factual information to patients and caregivers. Providers typically initiated 
these interactions when they explained the patients’ test results, disease progression, 
treatment options, or the cause of their symptoms. Sometimes the providers gave these 
explanations in response to questions by patients or caregivers.  The providers often did 
most of the talking and patients and caregivers said little or interjected brief remarks. In 
some cases, the patients said little seemingly because the information given to them was 
upsetting, complicated, or shocking. For example, an oncologist explained the second 
line treatment options for a patient whose disease had progressed and whose symptoms 
had worsened.  Following the explanation, the oncologist asked the patient if she had any 
questions, to which the patient replied “I haven’t heard half what you said.” Explanations 
of disease progression were at times followed by questions from patients and caregivers 
about life expectancy and options of surgery or radiation or discussions regarding 
preferences for maintaining quality of life versus continuing aggressive treatments. In one 
case, the provider explained that symptom management was the goal of treatment and 
that surgery was not an option.  
An example of an explanatory interaction follows.  In this interaction, an 
oncologist explained to a 73-year-old woman that her cancer was spreading and discussed 
her treatment options:  
Oncologist: They [lymph nodes] are all less than 5 millimeters but they are new 
and they are increasing, which means that the cancer is spreading.   
Patient: [takes a breath, possibly a gasp] 
Oncologist: But none of them is more than 5 millimeters.  What’s going on in 
the liver.  So, in the liver also there is the same thing.  There is an 
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increase in size and number of the [lymph nodes in the] liver.  
There is some fluid around your liver.  Also in some area between 
-- the liver is covered by a capsule and there is some bleeding 
underneath the capsule from the old tumor dying.  So there is some 
collection of fluid there.  So, remember when you had that one 
instance where you had a tumor and you had a lot of pain in that 
area? 
Patient: Yes. 
Oncologist: That could have triggered the tumor dying and bleeding and 
stretching the capsule could have triggered your pain.  And since 
then you haven’t had any pain? 
Patient: No. 
Oncologist: So that probably is what happened that time when we -- when I 
first saw you and you ended up in the hospital afterwards.  Now 
this is more pronounced so we can go back and say this is why you 
had the pain at the time.  So, clearly the disease is growing and I 
don't want to go over each lesion because the. . . each lesion does 
not matter.  The fact that the disease has increased in size and 
number tells me that we need to change course.  You know, just 
the Gemcitabine alone might not be enough… 
Agentic Interaction Pattern 
In 20 of the healthcare encounters, an interaction pattern occurred that we have 
labeled as agentic interactions. Agentic interactions are those in which patients and/or 
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caregivers were particularly vocal during discussions with providers and/or very involved 
in making treatment decisions. In some of these interactions, patients or caregivers 
seemed to experience some urgency to relay information to providers. Sometimes 
patients or caregivers came prepared with lists of questions or topics they wanted to 
discuss or used notes or journals as prompts to ensure their concerns were discussed. For 
example, one caregiver mentioned to the provider several times that she “wrote my 
notes” and asked if she could read them. In other cases, patients or caregivers clearly 
stated what they wished to discuss or repeated their concerns or remarks several times 
until their issues were acknowledged by the providers. Some caregivers actively 
advocated for the patients whereas other caregivers contradicted the patients.  In one 
case, a patient denied that he was troubled by his fatigue whereas his wife voiced her 
concern to the provider that her husband “slept around the clock.”  Providers were 
typically responsive to the patients or caregivers who took control of the discussions, 
although a few patients or caregivers apologized for “pushing” or “questioning” 
providers.  
An example of an agentic interaction follows.  In this interaction, a 67-year-old man 
and his daughter talked about the severe taste change that was of concern to them both:   
Patient: You know, I just got through discussing that. My appetite, I want to 
eat.  The problem I have doctor, and . . . is. . . when I eat everything 
tastes bitter. 
Oncologist: I see. 
Patient: And it’s hard to eat. It’s hard - even when you want to eat it’s hard 
to sustain yourself when you’re trying to eat something and the food 
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doesn’t taste like food or you get that initial something sweet. And 
then, and on the back end as you swallow it or whatever, it’s bitter.  
So I'm constantly getting this food don’t taste like food, it’s this 
bitterness that’s going on. 
Oncologist: Are there any foods that you still enjoy or is this something that’s 
everything? 
Patient: It’s a lot of foods that I enjoy and those are the ones I go after. 
Oncologist: I see. 
Patient: But I still get this, like last night I had a little, I wanted to have a 
little piece of pizza, you know, just a taste of tomato sauce. 
Oncologist: Yeah. [keyboarding]  
Patient: And that kind of thing. And I couldn’t eat it. It was just bitter.  Um. 
. . that’s a problem for me, one issue right now I don't know how to 
deal with. 
Oncologist: Okay. 
Patient: Because it’s like I know to eat, my family is constantly on me about 
eating. And I know what you told me what I should be trying to do 
is the small meals. Okay.  So those -- it’s just the problem is when I 
do try to eat something it’s. . . it’s the taste.  I don't have the taste 
that I would normally associate with those foods that I like.  And so 
this is an issue. 
Oncologist: And that’s probably the chemo. 
  
97 
 
Patient: Yeah.  This is an issue.  I don't really know how to get around it. 
My wife says eat anyway. And i said -  
Caregiver: Well, it’s so bitter it’s disgusting. 
Patient: And I said, baby, it’s hard to eat when. . . when. . . what you’re 
eating is either doesn’t have a taste that you normally associate it 
with so it’s not as desirable as before. 
Checklist Interaction Pattern 
In 16 of the healthcare encounters, an interaction pattern occurred that we have 
labeled as checklist interactions.  Checklist interactions are interactions in which the 
providers asked a series of questions in rote fashion, as if they were “going down” a list. 
The providers typically dominated these discussions. The questions were often closed-
ended and focused on the patients’ signs and symptoms, although in some cases the 
questions were focused on the patients’ medication regime.  The patients typically 
responded with brief answers, and, at times, the providers asked new questions before the 
patients completely answered the prior ones.  For example, in one instance, the patient 
began to respond to a question about appetite, and the provider moved on to another 
question about weight loss. Sometimes caregivers chimed in to convey additional 
information.  
An example of a checklist interaction follows.  In this interaction, the oncologist 
asked a series of questions when performing physical exam on a 59-year-old man while 
his wife was present:  
Oncologist: Do you have an appetite? 
Patient: No. I’m not hungry. I… 
  
98 
 
Oncologist: Stick out your tongue for me.  Deep breaths. You were having 
regular  
bowel movements. 
Patient: Yeah, like every other day, too. 
Oncologist: Solid or loose? 
Patient: I’d say . . .  solid.  Yeah, solid.   
Oncologist: Pain here as I press? 
Patient: [Non verbal reply.] 
Oncologist: Fevers at all? 
Patient: None. 
Oncologist: Shaking, chills? 
Patient: None.  I think for the most… 
Caregiver: So, he’s not on [Emend]…Is he?  It seems like… 
Patient: I think they give me that on at the… 
Caregiver: Which they have different names.  It could be. 
Oncologist: You’re getting … a steroid.  But you’re not getting Emend. 
Cross-purpose Interaction Pattern 
In 14 of the healthcare encounters, an interaction pattern occurred that we have 
labeled as cross-purpose interactions. Cross-purpose interactions are those in which the 
patients and/or caregivers and providers seemed to have differing agendas and failed to 
acknowledge the remarks of the other.  Often the providers changed the focus of the 
discussion without attending to concerns expressed by the patients or caregivers. For 
example, one patient mentioned how his fatigue was negatively affecting the quality of 
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his life and questioned the value of chemotherapy. His provider did not acknowledge his 
distress but rather stressed that his cancer was well-controlled and briefly assured her that 
the fatigue would eventually subside.  Some of the concerns of the patients and 
caregivers that were disregarded by the providers were stated explicitly and repeatedly 
whereas other concerns, especially those related to emotional distress or vague 
discomforts, were conveyed indirectly. For example, when one patient lamented that it 
was hard to accept the news that her disease had progressed because she still felt good, 
the provider replied, “[There is] no reason to think that feeling good actually is a bad 
thing.” Another patient said, “It [chemotherapy] doesn’t really knock me out.  It just 
makes. . . just. . . like I want to lay down but then I’m restless and I get up and I’ll lay 
down again.” To this his provider replied, “Let’s leave things [chemotherapy dose] as 
they are.”  In some cases, the patients or caregivers did not acknowledge remarks made 
by the providers or changed topics.  For example, when one provider asked about a 
patient’s diarrhea, the patient did not answer but talked instead about taking pancreatic 
enzymes and her blood pressure medicines.  
An example of a cross-purpose interaction follows.  In this interaction, a 73-year 
old patient, his wife, and the provider all seemed to have different agendas regarding 
addressing the patient’s symptoms. 
Patient: Because if I was to poke right in here. 
Oncologist: A huh? 
Patient: It’s not a pain but it aches really hard. 
Oncologist: Hard.  So have you been able to eat much? 
Patient: I don’t eat at all. 
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Caregiver: Well, he’s. . . he eats very little.  For a while he was hardly eating.  
Luckily he will drink the Glucerna. 
Oncologist: Okay. 
Caregiver: He’ll drink that.  And something like maybe oatmeal. 
Oncologist: Um hmm, okay. 
Patient: Cup of tea. 
Oncologist: Right.  And you just don’t have the appetite for it? 
Caregiver: Definitely. 
Patient: Don’t have any taste there. 
Oncologist: We can control the pain because. . . 
Empathic Interaction Pattern 
In 12 of the healthcare encounters, an interaction pattern occurred that we have 
labeled as empathic interactions. Empathic interactions are those in which the providers 
showed, or attempted to show, that they understood and cared about the emotions or 
experiences of the patients and/or caregivers.  These interactions often occurred when 
patients or caregivers expressed strong emotions or relayed upsetting experiences. For 
instance, one patient cried when she talked about the suffering of another patient with 
pancreatic cancer at the end of life.  In response, her oncologist acknowledged her 
feelings; he stated, “I'm sorry to hear this…I know it’s difficult to see those cases that the 
end of life might be painful.”  Sometimes providers acknowledged the difficulty of the 
patients’ treatment by saying they were “doing great” or that they were “tough.” Some 
providers provided brief empathic responses but then negated in some way the feelings 
expressed by patients and/or caregivers. For example, one patient appeared distressed 
  
101 
 
after the provider reported that imaging had shown a growth in the patient’s tumors. Her 
oncologist empathically responded, “I see you are really distressed and I can understand.” 
When the patient stated that she was distressed because she felt so good, the oncologist 
remarked that the patient was “hopefully not as surprised” as she could have been had the 
provider not prepared her for this outcome. Sometimes the providers’ empathic responses 
did not seem to “hit the mark” in accurately reflecting the patients’ feelings. For example, 
when a caregiver talked about feeling powerless to manage her husband’s fatigue and 
eating problems, the provider replied,  ”Yeah… we’re hopeful about the marker coming 
down.  We’re doing everything we can.” 
An example of an empathic interaction follows.  In this interaction, a provider 
attempts to respond empathically to a 69-year-old patient who expressed distress over her 
hair loss from chemotherapy: 
Patient: And. . . um. . . I just discovered, what, about 3 days ago, my hair. 
Oncologist: This chemo started making your hair fall out? 
Caregiver: Um hmm.  
Patient: And I was very depressed. 
Oncologist: I'm sorry. 
Patient: I know it happens. It didn’t happen the first time, the first time I 
had chemo. 
Oncologist: I know.  
Patient: So, I figured, you know, well okay, I'm one of the ones that it’s not 
gonna happen to.  But well, you know, this is a wig that I have on. 
My hair, starting from back here up to about right here is all gone. 
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Oncologist: I'm sorry, [Patient]. 
Patient: Yeah. 
Oncologist: It’s hard to tell because you always look good and this wig is so 
much like your real hair that it’s very hard to tell. You know?  And 
a lot of people, I know especially African Americans sometimes 
have all kinds of braids and they change their style so much that 
it’s hard to, for people that don’t know, to tell that this is all 
happening. 
Patient: Yeah. 
Oncologist: But I know you can tell and that must be upsetting and I'm sorry. 
So what to do, some of these chemos, the newer ones, they’re 
stronger, they’re better in some ways but then their side effects are 
also a little bit, you know, more.  And as long as the other things 
that affect quality of life like, you know, eating and energy, you’re 
not too badly affected, most patients say okay, I can wear a wig for 
a while. 
Patient: Right. 
Oncologist: And it will grow back, you know, down the road if this chemo is 
not necessary because the cancer is all gone or it’s under control 
and we can take a break or something, then certainly the hair 
would come back. Hopefully.  It does, it does. Everyone’s comes 
back. Of course it may look a little different.  It might be curlier or 
straighter. 
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Admonishing Interaction Pattern 
In 6 of the healthcare encounters, an interaction pattern occurred that we have 
labeled as admonishing interactions. Admonishing interactions are those in which 
providers cautioned patients and caregivers against behaviors thought not to be in the 
patients’ best interest or gently scolded them for taking certain actions or voicing certain 
opinions. When a caregiver mentioned that she thought the infection was a side effect of 
chemotherapy, the provider replied, “Just because you say it is doesn’t mean that it was.” 
In some cases, providers chided patients for not listening to them or failing to understand 
something the providers had said. For example, when a 76-year-old man said that his 
provider had not discussed surgery as a treatment option, the provider said this was “not 
true.” The provider said, “[What ] I'm giving you is clearly across the board [the] 
standard of care.” When the patient mentioned seeking a second opinion, the provider 
replied, “I don't care where you go, who[ever] says it’s standard of care to cut this out is 
not telling you the truth.” In this interaction pattern, patients or caregivers often agreed 
with the providers or responded in a deferent manner. For example, one patient took 
antibiotics for urinary tract infection without notifying the provider. The provider 
instructed the patient to call him when the patient had symptoms rather than taking 
antibiotics. To this the patient responded, “I promise I won’t do it again.” In other cases, 
patients and/or caregivers resisted the providers’ admonishments.  For example, when 
one provider disapproved of the patient cutting back on his pain medicine, the caregiver 
said, “You said to use it, on my notes, use it as needed.” 
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An example of an admonishing interaction follows. In this interaction, the 
provider, an 80-year-old patient, and her son discussed the patient driving while taking 
pain medication: 
Oncologist: Had you just. . . are you careful about when you take your pain 
medicine and driving? 
Patient: Well, I was. . . I find myself weaving sometimes and. . . I don't like 
to drive with a lot of people because they tend to weave. Do you 
know what I mean? 
Oncologist: Well, you’re not filling me with a lot of confidence here. 
Patient: [Chuckles] No, I don’t. . . like I knew I didn’t feel good Sunday.  I 
never left my blankie… 
Caregiver: But it’s not a frequent occurrence when you’re driving. 
Patient: Oh, no, it was happening on Easter…when I was going to [name of 
relative].  So… I got off on the wrong place, and I wound up on 
those 3 roundabouts…Have you ever been on roundabouts…? 
Oncologist: I know what you mean, yeah…Well, that is a little scary…So how 
much driving are you doing since then? 
Patient: Oh, I drive, like to mah jong a couple of days a week and. . .  
Oncologist: Is that like a few blocks or is that halfway across the city?...What do 
you do that for? 
Patient: [Makes a fun noise]: Pow!  [Chuckles] Slots. 
Oncologist: Do you have a friend that can go with you? 
Patient: Why?  I have to take my car. 
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Oncologist: I don't like this, what you’re telling me about your driving, that’s 
why. 
Patient: Oh.  Well, basically I don’t drive on the days that I’m really feeling 
blech.  I know when to drive…And the people that want to pick me 
up, like my sister, believe me, I’m better off driving.  [Chuckles] 
She’s 85 years old and I think she’s beginning to get a little flaky. 
Oncologist: Yeah, but she’s not on pain medicine.  That’s what I’m concerned 
about. 
Patient: I never feel tired from it…I mean I go to bed at 2 o’clock in the 
morning. 
Oncologist: Well, I understand but it’s like alcohol.  You don’t have to be falling 
down drunk to have decreased reflexes and maybe that’s why you 
were weaving a little bit. 
Patient: … I said my driving days are numbered if I feel like I did 
today…I’m not dumb. 
Oncologist: You’ve heard me and I know you’re not dumb.  So. 
Diverging Interaction Pattern 
In 4 of the healthcare encounters, an interaction pattern occurred that we have 
labeled as diverging interactions. Diverging interactions are those in which providers and 
patients and/or caregivers expressed a disagreement. Some of the disagreements were 
related to the meaning or importance of the patients’ symptoms. For example, when a 
patient stated that he ate less because he felt full easily, his provider replied, “But you 
used to eat until you got full, right...So what’s the difference?” Others were related to 
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treatment decisions. For example, while a patient and his caregiver requested surgery, the 
provider said that he’s “not a fan” of surgery.  Some of these interactions seemed tense. 
For example, when a provider stated that it was “unusual” to expect a life expectancy 
longer than a year given the patient’s disease progression, the caregiver said, “Why?  His 
case was unusual.” When the provider supported his argument with grim statistics, the 
patient replied, “I’ll be a statistic [exception].”  
An example of a diverging interaction follows. In this interaction, the 76-year-old 
man, his wife, and the provider had different opinions about the cause of the patient’s 
pneumonia. Later, the patient also argued that he received different information from 
providers in the same facility.   
Oncologist: That could have been a different virus that led to your decreased 
immunity that led to your pneumonia, actually.  That’s probably the 
most likely thing. 
Caregiver: But generally that kind of stuff starts getting better after 3 or 4 days. 
Oncologist: Yes. 
Caregiver: If it’s a virus. 
Oncologist: Right. 
Caregiver: And this wasn’t getting better. 
Oncologist: Right. 
Caregiver: And that’s when we called, it had been like the fourth or fifth day. 
And by the time he [another provider] could see us it was 7 days. 
Oncologist: I'll bet you anything it was a virus.  You didn’t think it was getting 
better because you got a subsequent pneumonia after the virus 
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happened. And that’s called a secondary super infection.  That 
actually happens a lot.  I. . . I personally think it came about 
because of an initial virus more than anything and I, personally 
myself don’t think this has anything to do with the Everolimus.  But 
prove me wrong -- I hope you don’t because I don't want you to 
have anymore infections. 
Caregiver: We don’t want to prove you wrong. 
Oncologist: I really do think you are tolerating very well.  I see no reason to 
lower the dose. It’s doing what we asked it to do…I'm not pushing 
surgery by any means but if it’s something that you guys want to 
talk about then you guys should get together and talk about it. 
Patient: Thank you. We’ve been bothered all along about the. . . we saw Dr. 
[Name] first and then you. 
Oncologist: Sure, sure, sure. 
Patient: A couple of times.  And we saw him again, gosh, it must have been 
August or so. 
Oncologist: Right. 
Caregiver: July. 
Patient: And we’ve seen you a couple of times since.  And it just didn’t 
seem like there was, you know, we came into this thing thinking 
you guys were a team. And we didn’t feel that this team thing was a 
reality.  That you had one. . . set. You know, you were definite on 
keeping me on this for ten years if it continued to work -  
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Discussion 
The findings of this study describe how patients with APC, their caregivers, and 
healthcare providers interacted when discussing symptoms or symptom management 
during naturally occurring healthcare encounters. We identified eight unique interaction 
patterns: collaborative interactions, explanatory interactions, agentic interactions, 
checklist interactions, cross-purpose interactions, empathic interactions, admonishing 
interactions, and diverging interactions. Each interaction pattern varied according to the 
communication behaviors of each participant, how the interactions flowed, and which 
participant dominated the interactions.  
Our findings can be interpreted according to the Dual Process Theory of 
Supportive Message Outcomes. 4-11 Specifically, two main constructs from the Dual 
Process Theory resonate with the interactions patterns identified in this study: verbal 
person centeredness (VPC) and patient and/or caregiver participation.   
Verbal Person Centeredness (VPC) 
According to the Dual Process Theory, VPC is “the extent to which messages 
explicitly acknowledge, elaborate, legitimize, and contextualize the feelings and 
perspective of a distressed other.” 4-22 Messages with high VPC help message recipients 
describe their feelings and explore the meaning of those feelings in the context of the 
recipients’ life situations. 4-23 VPC is evident in patient-centered communication in which 
a provider elicits, shows understanding of, or validates a patient’s perspective.7 Provider 
behaviors associated with VPC include avoiding interruptions, establishing the purpose 
of the visit, encouraging patient participation, eliciting and validating the patient’s 
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emotions, checking for patient understanding, and offering encouragement and support. 4-
7 Patient-centered communication has been long advocated by healthcare experts. 4-7, 4-24  
In our findings, high VPC was particularly evident in the pattern of collaborative 
interactions. In this pattern, providers often acknowledged patients’ concerns, used open-
ended questions, and sought the perspectives of patients and/or caregivers in making 
treatment decisions.  High VPC was also apparent in the pattern of empathic interactions.  
As found in other studies, 4-25 an important component of the healthcare encounters in our 
study involved providers expressing empathy by addressing patients’ and/or caregivers’ 
distressing emotions and acknowledging their adverse situations associated with their 
APC and its treatment. Such provider communication has been shown to have therapeutic 
value and positive effects on health outcomes such as higher medication-related self-
efficacy. 4-25-4-27   
In contrast, low VPC was manifest in the patterns of checklist, cross-purpose, 
admonishing, and diverging interactions. In these interactions, providers did not 
acknowledge patients’ and/or caregivers’ perspectives but instead asked a series of 
questions without much input from them (checklist interactions), carried on discussions 
without realizing they had a different agenda (cross-purpose), scolded them for some of 
their thoughts or actions (admonishing interactions), and openly disagreed with their 
points of view (diverging interactions).  Other studies have shown that provider 
communications that are not patient-centered can negatively affect patient outcomes by 
leading to low compliance with, passive participation in, or dissatisfaction with care. 4-15, 
4-16, 4-25, 4-28  
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Level of Participation 
Patient and/or caregiver level of participation is the extent to which they are 
motivated, ask questions, present and process information, express concerns, and state 
their preferences during their healthcare encounters. 4-29 A high level of patient and/or 
caregiver participation was most evident in the pattern of agentic interactions.  In this 
interaction pattern, patients and/or caregivers were particularly active in the encounters 
and often dominated discussions by expressing their needs, reporting information they 
deemed important, and getting their questions answered.  
The levels of participation varied in the pattern of explanatory interactions.  In 
several instances, patients did not actively respond to the information given to them or 
ask questions about it, despite that some of the information was related to the patients’ 
poor prognosis.  In other cases, explanations given by providers about test results or 
disease progression actually prompted patients and caregivers to become actively 
involved in the discussions as they responded to the information by asking critical 
questions about life expectancy and treatment options.  Often provider explanations 
triggered meaningful end-of-life discussions. 
Not surprisingly, some patterns of interactions that were low in VPC were also low 
in patient and/or caregiver participation. In particular, patient and/or caregiver 
participation in check-list and admonishing interactions was typically low. However, 
patients and/or caregivers could have high levels of participation in the patterns of cross-
purpose and diverging interactions.   
The results of our study are thus consistent with current communication theories 
and other research studies of patient-provider communication.  However, while most 
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studies have measured specific communication behaviors (e.g., asking questions) 4-29, 4-30 
and factors that influence communication (e.g., beliefs about control and perceived 
quality of care),4-31 our findings add to the literature by providing a qualitatively derived 
typology of interaction patterns based on naturally occurring healthcare encounters and 
robust exemplars of each type of interaction.  
Limitations 
Our findings should be understood in the context of the study limitations. The 
major limitation is that we used transcripts of healthcare encounters that had been 
established for a larger study designed to test a communication intervention. We 
therefore were able to analyze only the verbal communication that occurred in the 
encounters but did not have information about non-verbal behaviors.  In addition, we 
analyzed transcripts of only one encounter and thus we were not able to explore how the 
interaction patterns may vary across time as the patient/provider relationships evolve.  
Practice Implications 
Despite these limitations, our findings have several implications for healthcare 
providers. The typology of interaction patterns might serve as a useful heuristic by which 
providers can reflect on their own interactions with patients and/or caregivers in efforts to 
improve communication. For example, the typology may serve as a springboard for 
discussions of strategies to facilitate interactions patterns likely to be associated with 
better communication (e.g., empathic interactions) or to increase provider awareness of 
patterns that may impede effective communication (e.g., cross-purpose or diverging 
interactions).  
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Future Studies 
Although this study provides a basic description of a variety of types of interaction 
patterns, future research would be needed to validate and perhaps expand the typology. 
We recommend longitudinal studies that could capture how interaction patterns might 
change over time and would allow for researchers to conduct follow-up interviews with 
patients, caregivers, and providers about how they experienced the encounters and what 
might have influenced their behaviors during the encounters. Such studies would provide 
a more robust and dynamic model of interaction patterns.  Ultimately studies would be 
needed to examine the relationship between interaction patterns, factors that influence 
those patterns, and patient outcomes, such as symptom management and satisfaction.  
Conclusion 
To our knowledge, this is the first study to examine naturally occurring 
patient/caregiver-provider symptom discussions in healthcare encounters for patients with 
APC.  The typology of interaction patterns that we identified reflects the unique and 
varied ways that discussions related to symptoms and symptom management in this 
population can unfold.  Although we recognize that more research is needed to validate 
the typology and to explore how the patterns are related to patient outcomes, the typology 
can be used to initiate conversations about how communication between patients/ 
caregivers and providers can be enhanced.  
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CHAPTER FIVE 
Managing symptoms effectively is imperative for patients living with APC due to 
their limited life expectancy, complicated treatment regimes, rapid physical deterioration, 
and the debilitating nature of some of the symptoms,5-1, 5-2 Yet patients with APC often 
experience severe and poorly controlled symptoms that negatively affect their physical 
functioning, quality of life, and decision-making at end of life. 5-3-5-6 Communication 
about symptoms with providers plays an important role in symptom management. 5-3 Due 
to the importance of high quality symptom management in this population, more 
information is needed about the symptom experiences of patients with APC and about 
how communication about these symptoms occurs during healthcare encounters with 
providers. 
The purpose of this dissertation is to advance the sciences of nursing, symptom 
management, and patient/caregiver and provider communication in patients with APC. 
The aims of this dissertation are to (1) synthesize current evidence regarding APC 
patients’ symptom experiences, (2) examine recorded healthcare encounters between 
patients with APC, their caregivers, and healthcare providers to better understand the 
symptom experience of patients with APC as told to their healthcare providers, and (3) 
develop a typology to describe patterns of interactions between patients with APC, their 
caregivers, and healthcare providers in regards to symptoms and symptom management.  
The findings of the dissertation will be disseminated in three sub-studies. Sub-study 
1 (Chapter 2) addresses Aim 1; Sub-study 2 (Chapter 3) addresses Aim 2; and Sub-study 
3 (Chapter 4) addresses Aim 3. The key findings from the three sub-studies, the strengths 
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and limitations of the studies, recommendations for future research, and the clinical 
implications of the findings are discussed below. 
Sub-study 1 (Chapter 2):  The Symptom Experience of Patients with Advanced 
Pancreatic Cancer: An Integrative Review 
Because research related to the symptom experiences of patients with APC had 
not been adequately synthesized, an integrative review of this research was conducted 
using Whittemore and Knafl’s approach. 5-7 We searched and selected literature from four 
healthcare databases based on pre-determined inclusion and exclusion criteria. A total of 
16 quantitative studies that included over 1630 pancreatic patients were included in this 
review.   
Three major findings emerged from this integrative review. First, physical 
symptoms, especially pain, were the primary focus of most studies, with only 
approximately half of the studies discussing psychological symptoms. Second, fatigue, 
loss of appetite, and pain were the symptoms most often reported, and these symptoms 
were often reported as severe. Third, this research has been limited by designs that do not 
cover the full range of possible symptoms and that use a variety of different symptom 
measures, therefore making comparisons across studies difficult.  Results of this 
integrative review inform both clinical practice and future research by identifying 
problematic symptoms that may have a profound effect on APC and their caregivers. In 
addition, this review identified limitations of previous research and supported the need 
for qualitative research to deepen our understanding of the symptom experiences of 
patients with APC. 
  
120 
 
Sub-study 2 (Chapter 3): Symptom Experiences in Patients with Advanced 
Pancreatic Cancer as Reported During Healthcare Encounters 
Although several studies have measured the occurrence and severity of symptoms 
in patients with APC, 5-2 little is known about how patients and caregivers experience 
these symptoms and how the symptoms affect the quality of their lives. A qualitative 
descriptive study was therefore conducted to describe how patients with APC and their 
caregivers discussed symptoms with their providers during naturally occurring healthcare 
encounters. A total of 37 transcripts drawn from a larger randomized trial of a 
communication intervention were analyzed using standard content analysis.   
Four major findings emerged in this study. First, patients and caregivers primarily 
discussed the following ten types of symptoms: pain, fatigue, abnormal bowel 
movements, decreased appetite, nausea and vomiting, sleeping problems, neurological 
problems, skin problems, taste changes, and psychological distress. Some of these 
symptoms were described as intense or highly distressing. Second, patients and 
caregivers discussed a range of factors they believed contributed to patients’ symptoms, 
especially the progression of the cancer and the effects of chemotherapy. Third, patients 
and caregivers revealed that patients’ symptoms often impaired the quality of their lives, 
caused psychological distress, and impaired their cognitive functioning. Fourth, patients 
and caregivers mentioned a variety of strategies that were used to manage symptoms, 
including taking medications for pain, changing eating habits for appetite change and 
nausea, and exercising to combat fatigue. Findings from this qualitative descriptive study 
support and extend existing evidence and provide a more nuanced understanding 
regarding symptom experiences from patients’ and caregivers’ perspectives. The findings 
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indicate that providers should inquire about a wide range of symptoms and encourage 
patients and caregivers to discuss how they try to manage the symptoms and how the 
symptoms impact their day-to-day lives. 
Sub-study 3 (Chapter 4): Patterns of Interactions Among Patients with Advanced 
Pancreatic Cancer, Their Caregivers, and Healthcare Providers During Symptom 
Discussions 
Because few studies have been conducted that examine interactions between 
patients with APC, their caregivers, and their providers, this study used thematic analysis 
to develop a typology to describe patterns of interactions in regards to symptoms and 
symptom management. The 37 transcripts from the larger randomized intervention study 
mentioned above were analyzed for this purpose.  
Eight patient/caregiver-provider interaction patterns were identified: collaborative 
interactions, explanatory interactions, agentic interactions, checklist interactions, cross-
purpose interactions, empathic interactions, admonishing interactions, and diverging 
interactions. These interaction patterns varied according to the communication behaviors 
of each participant, how the interactions flowed, and which participant dominated the 
interactions. The results especially resonated with the Dual Process Theory of Supportive 
Message Outcomes. 5-8 With further validation, the typology can be used in provider and 
patient educational programs as a springboard for discussion of interaction patterns that 
facilitate or hinder patient-centered communication regarding symptoms and symptom 
management.  
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Summary 
The findings of all three studies reveal that patients with APC experience a 
myriad of symptoms that are of great concern to them and their caregivers.  In many 
cases, patients experience severe symptoms and the symptoms can significantly affect the 
quality of their lives and the lives of their caregivers. Psychological as well as physical 
symptoms can be troubling. The ways in which symptom discussions unfold in healthcare 
encounters also vary considerably. Some interactions regarding symptom discussions can 
be patient-centered and facilitate symptom discussions, likely leading to better symptom 
management. Other interactions do not focus on the patients and/or caregivers concerns 
and thus could possibly interfere with symptom management. The findings of all three 
studies suggest that patients with APC and their caregivers need ample opportunities to 
describe their symptoms fully and to discuss the meaning the symptoms have for their 
quality of life and illness course.  
Comparing findings between sub-study 1 and 2 allows us to do triangulation to 
provide deeper insight regarding symptom experience in APC population. While major 
symptoms, such as pain, fatigue, loss of appetite, and digestive symptoms were 
overlapped in both sub-study 1 and 2, some symptoms identified by sub-study 2 were 
seldom addressed by quantitative studies analyzed in sub-study 1 and vice versa (table 5-
1). For example, some studies addressed respiratory symptoms and oral dryness which 
were infrequently mentioned by our patients and caregivers during health encounters. On 
the other hand, our patients and caregivers described significant taste change, skin 
problems, and neurological problems which received little attention in most quantitative 
studies. Moreover, our patients described their neurological problems in different ways 
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(e.g., neuropathy, abnormal sensation, tingling or numbness) while sub-study 1 shows 
that only one instrument measures numbness and no instrument addresses other 
neurological problems. In terms of psychological symptoms, most quantitative studies 
included in sub-study 1 focused on depression and anxiety while our patients and 
caregivers discussed a wide range of their psychological distress. Our findings of sub-
study 2 also demonstrate patients and caregivers’ experience and concerns regarding 
quality and distress dimensions of symptoms which were not the focus of the quantitative 
studies.  
Innovation and Strengths 
This dissertation was innovative in several ways. First, to our knowledge, it was 
the first study to synthesize current evidence regarding the symptom experiences of 
patients with APC.  Second, it was the first study to use a qualitative approach to explore 
the symptom experiences of patients with APC based on their own words and those of 
their caregivers. Third, it was one of the few studies to examine what naturally occurring 
healthcare encounters reveal about the symptom experiences of patients with APC.  
Fourth, following the emerging research trends, 5-9, 5-10 this study considered how the 
verbal behaviors of all parties in healthcare encounters – patients, caregivers and 
providers – contributed to interactions regarding symptom experiences. By using 
innovative strategies, this dissertation uncovered new and useful information that builds 
on existing evidence regarding the importance of patient/caregiver and provider 
communication to improve symptoms and quality of life of patients with APC.  
Limitations 
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Findings of this dissertation must be examined in light of its limitations. The 
major limitation was that data were drawn from a larger intervention study that had 
produced the verbatim transcripts of the healthcare encounters. 5-11 Although these 
transcripts provided robust data to meet the study aims, they did not allow us explore the 
nonverbal communication that occurred during the encounters nor to explore issues with 
participants post-encounter, such as how they experienced the interactions overall, the 
rationale for some of their verbal communication, and concerns they might have wished 
to discuss but did not have the opportunity to do so. Another limitation was that the 
participants may have changed their behaviors or altered their communication patterns 
because they knew they were being recorded. The Hawthorne effect, in which 
participants may alter their behavior due to their awareness of being observed, may have 
been a factor in this research. 5-12 Although the sample size was limited by the constraints 
of the existing data set, the sample size was between the 20 and 30 participants, which is 
considered typical for qualitative studies. 5-13 The results of our study may not be fully 
transferred to non-white population as nearly 90% of our patients are white.  
Clinical Implications 
The findings of this research can be used in several ways. First, the findings 
presented in sub-study 1 and 2 can raise the awareness of providers about the wide range 
of symptoms experienced by patients with APC, the myriad ways in which they try to 
manage these symptoms, and how the symptoms can affect the quality of their lives. 
These findings suggest that providers should obtain symptom narratives from patients 
with APC and their caregivers to facilitate a patient-centered approach to symptom 
management. The typology of interaction patterns can be used to facilitate reflection and 
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discussion by both providers and patients and/or caregivers about what type of 
communication facilitates important symptom discussions and therefore enhances 
symptom management. The results presented in all three sub-studies may be used to 
enhance provider training in caring for and communicating with patients with APC. 
Recommendations for Future Research 
Several recommendations for future research are proposed. Frist, longitudinal 
qualitative and quantitative studies that follow patients and caregivers over time are 
needed to understand how patients’ symptom experiences and communication patterns 
with providers unfold from diagnosis to end-of-life. Second, more studies are needed to 
explore psychological symptoms as these symptoms were the least likely to be addressed 
in current literature, but which our findings suggest profoundly affect the lives of patients 
and caregivers. Third, future studies are needed to validate or expand the interaction 
typology so it may be used as a foundation to develop strategies to improve symptom 
discussions in healthcare encounters for this population.  
Conclusion 
To our knowledge, this dissertation was the first study to examine the symptom 
experiences of patients with APC in-depth and to explore the nature of interactions 
among patients with APC, their caregivers, and their provides regarding their symptom 
experiences. Our findings demonstrate that patients with APC and their families 
experienced multiple burdensome physical and psychological symptoms that negatively 
affects their lives. Our findings also revealed a variety of types of healthcare interaction 
patterns, some of which were patient-centered and some of which were not. The findings 
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have a number of implications that can further work aimed at developing strategies to 
improve symptom management in this vulnerable population.
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Table 5-1.  Symptoms Identified by Reviewed Studies and Current study  
 
 
 Bye  Labori  Braun Gao Larid  Allen Moningi Walter Stefaniak  Crippa  Seicean  Reyes-
Gibby  
Romanus Dobratz Muller Current study  
Ph
ys
ic
al
 
Pain  X  X  X  X  X  X  X  X  X  X  X  X  X  X  X  X  
Loss of 
appetite  
X  X  X  X  X  X       X     X  
Fatigue/ 
lack of 
energy 
X  X  X X  X  X   X  X   X  X     X  
Sleep   X X  X  X      X  X     X  
Respiratory   X X  X  X       X      
Oral 
dryness 
X  X           X      
Test 
change  
X                X  
Digestivea X  X  X  X  X  X  X     X  X     X  
Numbness             X     X (neurological 
problems) 
Ps
yc
ho
lo
gi
ca
l 
Senses of 
well-being 
X  X        X         
Anxiety X  X            X    X  
Depression/ 
sadness 
X  X       X    X  X  X    X  
Emotional 
distress/ 
mood 
disturbance 
           X     X  
Life 
enjoyment 
          X       
Fear of 
future 
health 
problems 
      X           
 
aDigestive symptoms includes nausea and vomiting, flatulence, altered bowel movement and indigestion 
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